AZN logo

AstraZeneca PLC

AZN
Healthcare|Drug Manufacturers - General|GB
$186.43
-0.42 (-0.22%)
DCF Value
$500.17
Graham Number
$72.85
Cash / Share
$5.23

Clinical Trials (507)

TrialConditionsPhaseStatusEnrollmentDesignDrug
NCT07476859
Effect of Intravenous Iron on Quality of Life in Older Patients With Acute Coronary Syndrome
Acute Coronary Syndromes (ACS), Iron Deficiencies
P4
Recruiting538RCT, Open-labelFerric Carboxymaltose Injection [Ferinject]
NCT07177417
Characterizing the Human Airway Immune Response to FluMist Vaccination
Healthy Young Adults, Influenza Vaccines
P4
Recruiting30RCT, Open-labelFluMist, inactivated influenza vaccine
NCT07647328
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
ER-Positive HER2-Negative Breast Cancer
P3
Recruiting150Open-labelCamizestrant, Ribociclib
NCT07430306
A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
P3
Recruiting245Open-labelAnifrolumab
NCT07000123
A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With Clinical ASCVD or at Risk for a First ASCVD Event
Cardiovascular Disease
P3
Active3,103RCT, Double-blindAZD0780, Placebo
NCT06904170
Durvalumab and Tremelimumab With or Without Hepatic Arterial Infusion of Chemotherapy in Hepatocellular Carcinoma
Hepatocellular Carcinoma
P2P3
Recruiting196RCT, Open-labelDurvalumab Plus Tremelimumab, HAIC (GEMOX)
NCT03875235
Durvalumab or Placebo in Combination With Gemcitabine/Cisplatin in Patients With 1st Line Advanced Biliary Tract Cancer (TOPAZ-1)
Biliary Tract Neoplasms
P3
Active810RCT, Double-blindDurvalumab, Placebo
NCT07205822
A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer
Breast Cancer
P3
Recruiting100Open-labelDato-DXd
NCT06952803
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
Prostate Cancer
P3
Recruiting700RCT, Double-blindSaruparib, Placebo, Abiraterone + Prednisolone/Prednisone, Androgen Deprivation Therapy (ADT)
NCT07005128
A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)
Small-cell Lung Cancer, Extensive Stage Small-cell Lung Cancer
P3
Active350RCT, Open-labelTarlatamab, Durvalumab, Carboplatin, Etoposide
NCT06989112
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
P3
Recruiting600RCT, Open-labelTrastuzumab deruxtecan, Rilvegostomig, Pembrolizumab, Carboplatin, Paclitaxel, Docetaxel
NCT04924608
Efficacy and Safety of Selumetinib in Adults With NF1 Who Have Symptomatic, Inoperable Plexiform Neurofibromas
Neurofibromatosis 1, Plexiform Neurofibroma (PN)
P3
Active145RCT, Double-blindSelumetinib
NCT07662135
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
Type 2 Diabetes Mellitus, Type 2 Diabetes With Chronic Kidney Disease
P3
Recruiting900RCT, Double-blindElecoglipron, Placebo
NCT07761117
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
P3
Recruiting6,950RCT, Double-blindElecoglipron, Placebo
NCT07363642
Phase 3b Study in Patients With Severe Asthma Treated With Tezepelumab
Severe Asthma
P3
Recruiting400Open-labelTezepelumab
NCT06564844
A Phase III, Randomised Study of Adjuvant Dato-DXd in Combination With Rilvegostomig or Rilvegostomig Monotherapy Versus Standard of Care, Following Complete Tumour Resection, in Participants With Stage I Adenocarcinoma NSCLC Who Are ctDNA-positive or Have High-risk Pathological Features
Non-small Cell Lung Cancer
P3
Active25RCT, Single-blindDatopotamab Deruxtecan, Rilvegostomig, Carboplatin, Cisplatin, Etoposide, Pemetrexed, Vinorelbine, UFT
NCT03778957
A Global Study to Evaluate Transarterial Chemoembolization (TACE) in Combination With Durvalumab and Bevacizumab Therapy in Patients With Locoregional Hepatocellular Carcinoma
Hepatocellular Carcinoma
P3
Active724RCT, Double-blindDurvalumab, Bevacizumab
NCT07775404
A Study to Investigate the Efficacy and Safety of Elecoglipron in Asian Participants With Obesity or Overweight With or Without Type 2 Diabetes Mellitus
Obesity, Overweight
P3
Recruiting351RCT, Double-blindElecoglipron, Placebo
NCT06350097
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Non-small Cell Lung Cancer
P3
Recruiting582RCT, Open-labelOsimertinib, Datopotamab Deruxtecan
NCT04191304
A Phase III Study to Evaluate the Efficacy and Safety of Benralizumab in Patients With Hypereosinophilic Syndrome (HES)
Hypereosinophilic Syndrome
P3
Active134RCT, Double-blindBenralizumab, Placebo
NCT05624450
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
Viral Lung Infection and Acute Respiratory Failure
P3
Recruiting3,527RCT, Double-blindTozorakimab, Placebo
NCT05374291
The RENAL LIFECYCLE Trial: A RCT to Assess the Effect of Dapagliflozin on Renal and Cardiovascular Outcomes in Patients With Severe CKD
Kidney Disease, Chronic, Renal Transplant Failure
P3
Active1,750RCT, Double-blindDapagliflozin 10 mg/day (oral), Placebo
NCT07764978
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
Newly Diagnosed Multiple Myeloma
P3
Recruiting750RCT, Open-labelAZD0120, Daratumumab, Dexamethasone, Isatuximab, Lenalidomide, Bortezomib, Cyclophosphamide, Fludarabine
NCT03682068
Study of Durvalumab Given With Chemotherapy, Durvalumab in Combination With Tremelimumab Given With Chemotherapy, or Chemotherapy in Patients With Unresectable Urothelial Cancer
Unresectable Locally Advanced Urothelial Cancer, Metastatic Urothelial Cancer
P3
Active1,246RCT, Open-labelDurvalumab, Tremelimumab, Cisplatin + Gemcitabine, Carboplatin + Gemcitabine
NCT02972840
A Study of BR Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreated MCL
Lymphoma, Mantle Cell
P3
Active635RCT, Double-blindAcalabrutinib, Bendamustine, Rituximab, Placebo
NCT06112379
A Phase III Randomised Study to Evaluate Dato-DXd and Durvalumab for Neoadjuvant/Adjuvant Treatment of Triple-Negative or Hormone Receptor-low/HER2-negative Breast Cancer
Breast Cancer
P3
Active1,902RCT, Open-labelDato-DXd, Durvalumab, Pembrolizumab, Doxorubicin, Epirubicin, Cyclophosphamide, Paclitaxel, Carboplatin, Capecitabine, Olaparib
NCT07784725
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Obesity or Overweight
P3
Recruiting2,500RCT, Double-blindLenbelintide, Placebo
NCT04960709
Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse Cisplatin
Muscle Invasive Bladder Cancer
P3
Active712RCT, Open-labelDurvalumab, Tremelimumab, Enfortumab Vedotin
NCT06467357
Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer
Biliary Tract Cancer
P3
Recruiting620RCT, Open-labelGemcitabine, Cisplatin, Durvalumab, Trastuzumab deruxtecan, Rilvegostomig
NCT03668340
AZD1775 in Women With Recurrent or Persistent Uterine Serous Carcinoma or Uterine Carcinosarcoma
Uterine Cancer
P2
Active49Open-labelAZD1775
NCT07285213
Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody
Clostridioides Difficile Infection
P2
Recruiting230RCT, Double-blindAZD5148
NCT07017179
This is a Multi-centre, Multi-drug, Platform Study in Chinese Participants Living With Obesity / Overweight
Obesity/Overweight
P2
Active16RCT, Double-blindAZD6234, Placebo, AZD9550, Plocebo, AZD6234 in combination with AZD9550, Placebo
NCT03899337
A Trial of CHOP-R Therapy, With or Without Acalabrutinib, in Patients With Newly Diagnosed Richter's Syndrome
Richter Syndrome
P2
Active72RCT, Open-labelAcalabrutinib, Cyclophosphamide, Doxorubicin, Vincristine, Prednisolone, Rituximab
NCT03932331
Study of Acalabrutinib in Chinese Adult Subjects With Relapsed or Refractory Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia or Other B-cell Malignancies
Phase I: Relapsed or Refractory B-cell Malignancies, Phase II Cohort A: Relapsed or Refractory Mantle Cell Lymphoma
P1P2
Active105Open-labelAcalabrutinib
NCT05801029
A Study to Investigate Safety and Efficacy of Osimertinib and Amivantamab in Participants With Non-small Cell Lung Cancer With Common Epidermal Growth Factor Receptor Mutations
Non-Small Cell Lung Cancer (NSCLC)
P2
Active60Open-labelOsimertinib, Amivantamab
NCT06921928
Study for AZD4360 in Participants With Advanced Solid Tumours
Gastric Cancer, Gastroesophageal Junction Cancer
P1P2
Active31Open-labelAZD4360
NCT06749457
A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
Staphylococcus Aureus
P1P2
Active242RCT, Double-blindAZD7760
NCT06535607
Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
Sub-study 1 Cervical Cancer (Volrustomig Monotherapy), Sub-study 2 Head and Neck Squamous Cell Carcinoma (Volrustomig Monotherapy)
P2
Recruiting257RCT, Open-labelVolrustomig, Cisplatin, Carboplatin, Paclitaxel, 5-FU
NCT05065554
ACALA-R In Predominantly Demyelinating IgM Mediated Neuropathy
IgM MGUS, Waldenstrom Macroglobulinemia
P2
Active12Open-labelAcalabrutinib, Rituximab
NCT07058519
A Study of Osimertinib-based Adaptive Treatment Guided by ctDNA EGFRm+ Monitoring in NSCLC
Locally Advanced or Metastatic EGFRm Non-small Cell Lung Cancer (NSCLC)
P2
Recruiting250Open-labelOsimertinib-based adaptive treatment, Osimertinib 80 MG
NCT04931654
A Study to Assess the Safety and Efficacy of AZD7789 in Participants With Advanced or Metastatic Solid Cancer
Carcinoma, Non-Small-Cell Lung, Gastric Cancer
P1P2
Active136RCT, Open-labelAZD7789
NCT03768570
Trimodality Therapy With/Out Durvalumab to Treat Patients With Muscle-Invasive Bladder Cancer
Bladder Cancer
P2
Active82RCT, Open-labelDurvalumab
NCT06680596
Detecting Tumor DNA in the Blood of HR+/HER2-low Metastatic Breast Cancer Patients to Find Candidates for T-DXd Therapy
Breast Cancer Metastatic, Breast Cancer Stage IV
P2
Recruiting80Open-labeltrastuzumab derxutecan
NCT07681596
A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma
Relapsed or Refractory Multiple Myeloma
P1P2
Recruiting101Open-labelAZD4045, Daratumumab, Aldesleukin
NCT06440993
Durvalumab + Intraductal Radiofrequency Ablation (ID-RFA) in Extra- and Intrahepatic Cholangiocarcinoma
Extrahepatic Cholangiocarcinoma, Unresectable Perihilar or Ductal CCA
P2
Recruiting42Open-labelGemcitabine, Cisplatin, Durvalumab
NCT03741426
WIRE - Novel Treatments in Renal Cell Cancer
Renal Cell Cancer
P2
Recruiting134Open-labelOlaparib, Cediranib, Volrustomig, Rilvegostomig
NCT05982678
Basket Study for Oligo-metastatic Breast Cancer
HER2-positive Breast Cancer
P2
Recruiting72Open-labelTrastuzumab deruxtecan
NCT07115043
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
Melanoma, Non-small Cell Lung Cancer
P1P2
Recruiting120Open-labelAZD6750, rilvegostomig
NCT06137118
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
B-cell Acute Lymphoblastic Leukemia (B-ALL)
P1P2
Recruiting255RCT, Open-labelSurovatamig
NCT06973564
JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration
Advanced Solid Tumors
P1P2
Recruiting344Open-labelJAB-23E73, Cetuximab
NCT03704480
Durvalumab + Tremelimumab ± Paclitaxel in Advanced BTC After Platinum Chemotherapy.
Advanced Biliary Tract Carcinoma
P2
Active106Open-labelDurvalumab, Tremelimumab
NCT05775159
Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer
Hepatocellular Carcinoma, Biliary Tract Cancer
P2
Active294Open-labelVolrustomig, Bevacizumab, Lenvatinib, Rilvegostomig, Gemcitabine, Cisplatin
NCT04214288
A Study to Investigate Efficacy and Safety With Oral AZD9833 Compared With Intramuscular Fulvestrant in Post-menopausal Women at Least 18 Years of Age With Advanced ER-positive HER2 Negative Breast Cancer
Advanced ER-Positive HER2-Negative Breast Cancer
P2
Active240RCT, Open-labelAZD9833, Fulvestrant
NCT07717840
A Study to Characterize the Safety and Immunogenicity of AZD6489 in Participants 60 Years of Age and Older (ARIES)
RSV Respiratory Syncytial Virus
P1P2
Active164RCT, Double-blindAZD6489, Licensed RSV vaccine #1, Licensed RSV vaccine #2
NCT05256641
Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma
Diffuse Large B-Cell Lymphoma, High-grade B-cell Lymphoma
P1P2
Recruiting24Open-labelAcalabrutinib
NCT07446855
Study of AZD4956 as Monotherapy and in Combination With Anti-Cancer Agents in Participants With Advanced/Metastatic Homologous Recombination Deficient Solid Tumours
Solid Tumours
P1P2
Recruiting180RCT, Open-labelAZD4956, Saruparib
NCT07485452
Boosting Osimertinib Blood Brain Barrier Penetration
Non-Small Cell Lung Cancer
P2
Recruiting7Open-labelOsimertinib & febuxostat
NCT02546661
Open-Label, Randomised, Multi-Drug, Biomarker-Directed, Phase 1b Study in Pts w/ Muscle Invasive Bladder Cancer
Muscle Invasive Bladder Cancer
P1
Active117RCT, Open-labelAZD4547, MEDI4736, Olaparib, AZD1775, Vistusertib, AZD9150, Selumetinib
NCT04556773
A Phase 1b Study of T-DXd Combinations in HER2-low Advanced or Metastatic Breast Cancer
Metastatic Breast Cancer
P1
Active138Open-labelTrastuzumab deruxtecan, Durvalumab, Paclitaxel, Capivasertib, Anastrozole, Fulvestrant, Capecitabine
NCT06564623
Targeting Driver Oncogenes With a Peptide Vaccine Plus Durvalumab and Tremelimumab for Patients With Biliary Tract Cancers (BTC)
Biliary Tract Cancers
P1
Recruiting25Open-labelmBTC vax [0.3 - 2.4 mg peptide + 0.5 mg Poly-ICLC (Hiltonol)], Durvalumab, Tremelimumab
NCT07723833
A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
Healthy Participants
P1
Recruiting152RCT, Open-labelElecoglipron Reference Formulation Dose A, Elecoglipron Test formulation 1 Dose A, Elecoglipron Reference Formulation Dose B, Elecoglipron Test formulation 1 Dose B, Elecoglipron Test formulation 2 Dose A, Elecoglipron Test formulation 2 Dose B
NCT03819465
A Study of Novel Anti-cancer Agents in Patients With Previously Untreated NSCLC
Metastatic Non-Small Cell Lung Cancer (NSCLC)
P1
Active175RCT, Open-labelDurvalumab, Danvatirsen, Oleclumab, MEDI5752, Pemetrexed, Carboplatin, Gemcitabine, Cisplatin, Nab-paclitaxel, AZD2936
NCT02264678
Ascending Doses of Ceralasertib in Combination With Chemotherapy and/or Novel Anti Cancer Agents
Adv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian Cancer
P1
Active358Open-labelAdministration of ceralasertib, Administration of ceralasertib in combination with olaparib, Administation of ceralasertib in combination with durvalumab, Administration of ceralasertib monotherapy, Administration of ceralasertib and olaparib, Administration of ceralasertib and durvalumab, Administration of ceralasertib in combination with AZD5305, Administration of ceralasertib in combination with carboplatin
NCT07073547
A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple Myeloma (DURGA-2)
Multiple Myeloma
P1
Recruiting40Open-labelAZD0120
NCT03641755
Olaparib + Sapacitabine in BRCA Mutant Breast Cancer
Breast Cancer
P1
Active10Open-labelSapacitabine, Olaparib
NCT06465810
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
Transthyretin Amyloidosis, ATTR-CM
Recruiting1,850—Treatment of transthyretin (ATTR) amyloidosis in observational study setting
NCT06252753
Observational Study Protocol: LIVER-R
Hepatobiliary Cancers
Recruiting4,000——
NCT06981169
PROPULSION SANTE: Inflammometry to Improve the Diagnostic Trajectory in Situations of Suspected Asthma in Children and Adults
Asthma, Inflammation
Recruiting1,500——
NCT07205666
The Eplontersen Pregnancy and Lactation Outcomes Study
Transthyretin Amyloidosis
Recruiting10——
NCT06491862
RACE-2L: Real-World Assessment of Clinical Practice and Outcomes in Non-squamous NSCLC After Failure of Platinum-based Chemotherapy in Brazil
Non-squamous Non-Small Cell Lung Cancer
Recruiting250——
NCT06417801
Minimally Interventional Study on Prevalence of Emerging ESR1 Mutations in Liquid Biopsy in Three Cohorts of Patients With Breast Cancer in Comparison With Patient's Baseline ESR1 Mutation Status as Defined by Tissue Profiling.
Metastatic Breast Cancer
Recruiting170——
NCT07338942
Implementation of Standardized Early Identification and Diagnosis for Transthyretin Amyloidosis (ATTR) in High-Risk Populations
ATTR-CM
N/A
Active4,000Open-label—
NCT05103605
Prospective Cohort of Locally Advanced and Metastatic Non-Small Cell Lung Cancer Patients With Activating EGFR Mutations
Non Small Cell Lung Cancer
Active274—Osimertinib
NCT07069829
Study of Clinical and Patient-reported Outcomes in Adults With Moderate to Severe COPD Treated With Breztri/Trixeo
Chronic Obstructive Pulmonary Disease
Recruiting1,400——
NCT06336330
Real-world Study on Dapagliflozin Usage in Patients With Heart Failure (HF) in Germany
Heart Diseases, Cardiovascular Diseases
Active831——
NCT06489964
Addressing Unfunded Vaccines Through a Co-payment Mechanism in Pharmacies
Preventable Disease, Vaccine
N/A
Recruiting600RCT, Open-label—
NCT06544629
Imjudo & Imfinzi PMS
Hepatocellular Carcinoma
Recruiting246——
NCT07419555
Belgian Lung Function Study
Chronic Respiratory Diseases
Recruiting5,000——
NCT06427876
Fasenra Pediatric Japan Post-Marketing Study(PMS)
Bronchial Asthma
Active40——
NCT06472310
Clinical and demOgRaphic Features of Patients With Uncontrolled Severe Asthma in Russia (CORSAR)
Severe Asthma
Recruiting5,000——
NCT03958136
Clinico-biological Data Collection Study of Metastatic Breast Cancer
Breast Cancer
N/A
Active289Open-labelBiomarkers blood, urine and microbiota samples
NCT07593196
HER2-positive Metastatic Breast Cancer in Kazakhstan
Metastatic Breast Cancer
Recruiting240——
NCT02819882
A Prospective Registry Study in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer (MBC)
Breast Neoplasms
Recruiting1,867——
NCT05573893
PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and Real-world Clinical Data in Patients With HER2-positive, HER2-low or HER2-ultralow Unresectable or Metastatic Breast Cancer Treated With Trastuzumab Deruxtecan
Breast Neoplasms, Breast Cancer
Recruiting800——
NCT07663409
The DEBATE Study "DEvelopment of Endotype-based Biomarkers for the Monitoring of Greek pATiEnts With CRSwNP"
CRSwNP or CRSsNP Patients
Recruiting230——
NCT00521365
Effectiveness of Quetiapine XR on the Control of Symptoms of Manic Phase of Bipolar Disorder.
Bipolar Disorder, Bipolar Affective Psychosis
P4
Completed88Open-labelQuetiapine 600mg
NCT00621153
Candesartan Effect in Second Stage Arterial Hypertension
Stage II Hypertension
P4
Completed214RCT, Open-labelCandesartan Cilexetil, Hydrochlorothiazide, Candesartan Cilexetil
NCT01443845
Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS)
COPD, COPD Exacerbation
P4
Completed2,354RCT, Double-blindRoflumilast, Placebo
NCT02919345
Assessment of Dapagliflozin Effect on Diabetic Endothelial Dysfunction of Brachial Artery
Diabetes Mellitus, Type 2, Coronary Artery Disease
P4
Completed98RCT, Open-labelDapagliflozin 10 mg, Glibenclamide 5 mg
NCT00489853
Evaluation of Efficacy on Exercise Tolerance of Symbicort (Budesonide/Formoterol) Compared to Placebo and Oxis in Patients With Severe COPD
Chronic Obstructive Pulmonary Disease
P4
Completed137RCT, Double-blindbudesonide/formoterol Turbuhaler 320/9µg, formoterol Turbuhaler 9µg
NCT02429765
Effect of Aclidinium/Formoterol on Nighttime Lung Function and Morning Symptoms in Chronic Obstructive Pulmonary Disease
COPD
P4
Completed40RCT, Double-blindACL/FOR, Placebo
NCT00631189
Evaluation of the Efficacy and Safety of Rosuvastatin 5 mg Versus Pravastatin 40 mg and Atorvastatin 10 mg in Type IIa and IIb Hypercholesterolaemic Patients
Type IIa and IIb Hypercholesterolaemia
P4
Completed668RCT, Double-blindRosuvastatin, Pravastatin, Atorvastatin
NCT01787097
Effect of Symbicort ® on GR in Sputum in COPD
Chronic Obstructive Lung Disease
P4
Completed31RCT, Open-labelSymbicort® total dose 400ug/12ug, Symbicort® total dose 800ug/24ug, Formoterol 24ug, BUD total dose 800ug
NCT00254241
Safety and Efficacy of Seroquel in First Episode Schizophrenia
Schizophrenia
P4
Completed80RCT, Single-blindSeroquel and Risperidone
NCT01006603
Saxagliptin Compared to Glimepiride in Elderly Type 2 Diabetes Patients, With Inadequate Glycemic Control on Metformin
Type 2 Diabetes Mellitus
P4
Completed957RCT, Double-blindSaxagliptin, Glimepiride
NCT00234390
PreAsthmaControl (PAC)
Asthma
P4
Completed400RCT, Double-blindPulmicort (budesonide) pMDI
NCT00237393
Quetiapine Treatment for Post-Traumatic Stress Disorder (PTSD)
PTSD
P4
Completed80RCT, Double-blindQuetiapine, Placebo
NCT00926393
Study Comparing the Tolerability of Seroquel IR With Seroquel XR in Patients With Bipolar Depression
Bipolar Depression
P4
Completed139RCT, Double-blindQuetiapine Immediate Release, Quetiapine Extended Release
NCT00295412
The Impact of Quetiapine on the Drug Abuse Patterns of Addicted Schizophrenic Patients
Schizophrenia, Substance Use Disorders
P4
Completed—Open-labelquetiapine (drug)
NCT00851461
Effect of Goserelin (Zoladex®) in Spinal and Bulbar Muscular Atrophy
Spinobulbar Muscular Atrophy, Kennedy's Disease
P4
Completed10RCT, Open-labelGoserelin
NCT02839889
Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation)
Cancer, Constipation
P4
Terminated12RCT, Double-blindNaloxegol, Placebo
NCT00477581
A Study to Compare the Effects of Exenatide and Sitagliptin on Postprandial Glucose in Subjects With Type 2 Diabetes Mellitus
Type 2 Diabetes Mellitus
P4
Completed102RCT, Double-blindexenatide, sitagliptin
NCT00272753
Effect of Budesonide / Formoterol Combination in Repeated AMP Provocations
Asthma
P4
Completed20RCT, Double-blindbudesonide/formoterol Turbuhaler, formoterol Turbuhaler, salbutamol
NCT00562081
The Virtual Asthma Clinic
Asthma
P4
Terminated27RCT, Single-blind—
NCT02585804
Treating to Reduce Albuminuria and Normalize Hemodynamic Function in Focal ScLerosis With dApagliflozin Trial Effects
Focal Segmental Glomerulosclerosis
P4
Completed10Open-labelDapagliflozin
NCT02663713
A Randomized, Pharmacodynamic Comparison of Low Dose Ticagrelor to Clopidogrel in Patients With Prior Myocardial Infarction
Myocardial Infarction, Diabetes Mellitus
P4
Completed20RCT, Single-blindTicagrelor, Clopidogrel
NCT01203917
Efficacy, Safety, Tolerability of Gefitinib as 1st Line in Caucasian Patients With EGFR Mutation Positive Advanced NSCLC
Caucasian Patients With EGFR Mutation Positive Advanced NSCLC
P4
Completed1,060Open-labelGefitinib
NCT00766350
Comparative Efficacy and Tolerability of Quetiapine XR and Amitriptyline in the Treatment of Fibromyalgia
Fibromyalgia
P4
Completed90RCT, Open-labelamitriptyline, quetiapine
NCT06374043
Decentralized N=1 Study: A Feasible Approach to Evaluate Individual Therapy Response to Dapagliflozin.
Diabetes Mellitus, Type 2, Diabetes Mellitus Type 2 With Proteinuria
P4
Completed20RCT, Double-blindDapagliflozin 10mg Tab, Placebo
NCT02972476
Microbiome Use to Stratify Use of Inhaled Corticosteroids: MUSIC Trial
Chronic Obstructive Pulmonary Disease
P4
Completed158RCT, Open-labelBudesonide & formoterol fumarate and Aclidinium bromide, Fluticasone 500 & salmeterol and Aclidinium bromide, Fluticasone 250 & salmeterol and Aclidinium bromide, Aclidinium bromide & formoterol fumarate
NCT04078152
Durvalumab Long-Term Safety and Efficacy Study
Solid Tumor
P4
Completed163Open-labelDurvalumab
NCT00870194
A Comparison of Adding Exenatide With Switching to Exenatide in Patients With Type 2 Diabetes Experiencing Inadequate Glycemic Control With Sitagliptin Plus Metformin
Type 2 Diabetes Mellitus
P4
Completed255RCT, Double-blindexenatide and sitagliptin, exenatide and placebo
NCT02518464
Ticagrelor Therapy for RefrACTORy Migraine Study
Migraine, Headache
P4
Completed40Open-labelTicagrelor 90 mg twice per day
NCT06590740
Establish FeNO Cut-off Value for Predicting Budesonide-formoterol Response in Chronic Cough Suggestive of CVA Patients.
Cough-Variant Asthma
P4
Completed1,000Open-labelBudesonide-Formoterol treatment
NCT00318968
Nexium RESPONSE Trial
GERD
P4
Completed1,000RCT, Double-blindEsomeprazole
NCT02153489
A Double-blind, Placebo-controlled, Crossover Study to Assess the Effect of Aclidinium Bromide 400 μg Bid on COPD Symptoms and Sleep Quality After 3 Weeks of Treatment in Patients With Stable Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)
Chronic Obstructive Pulmonary Disease (COPD)
P4
Completed30RCT, Double-blindAclidinium bromide, Placebo
NCT04219124
The Effect of a SGLT2 Inhibitor on Glucose Flux, Lipolysis and Exercise in Type 2 Diabetes
Type 2 Diabetes
P4
Completed9RCT, Double-blindIMP oral tablet, Placebo oral tablet
NCT00576316
Symbicort Maintenance and Reliever Therapy - Experience in Real Life Setting in Malaysia
Asthma
P4
Completed201Open-labelSymbicort Turbuhaler 160/4.5
NCT01826175
Comparison of Ticagrelor Versus Clopidogrel on Residual Thrombus Burden During PCI: an OCT Study
Acute Coronary Syndrome, Coronary Artery Disease
P4
Withdrawn—RCT, Single-blindTicagrelor, Clopidogrel
NCT00954122
Efficacy and Safety of SEROQUEL Extended Release (XR) in Acute Schizophrenia
Schizophrenia
P4
Completed35Open-labelQuetiapine XR (Seroquel XR)
NCT01242527
Epanova® for Lowering Very High Triglycerides
Severe Hypertriglyceridemia
P2P3
Completed399RCT, Double-blindplacebo, omefas, omefas, omefas
NCT05062759
Study to Assess the Effect of Tezepelumab on the Immune Response to Influenza Vaccination in Participants With Asthma
Moderate to Severe Asthma
P3
Completed70RCT, Double-blindTezepelumab, Placebo
NCT03303066
Efficacy and Safety of FG-4592 for Treatment of Anemia in Participants With Lower Risk Myelodysplastic Syndrome (MDS)
Anemia, Myelodysplastic Syndrome
P2P3
Completed43RCT, Double-blindFG-4592, Placebo
NCT02783573
A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease Dementia
Alzheimer's Disease
P3
Terminated1,722RCT, Double-blindLanabecestat, Placebo
NCT00852631
Seroquel XR in Adults With Schizophrenia
Schizophrenia
P3
Terminated28Open-labelQuetiapine fumarate (Seroquel)
NCT00640601
Study Evaluating the Clinical Benefit of SEROQUEL XR in Subjects With Schizophrenia
Schizophrenia
P3
Completed331Open-labelQuetiapine Fumarate Extended- Release
NCT00642187
New Version Pulmicort Turbuhaler USA Adults
Asthma
P3
Completed525RCT, Single-blindbudesonide, Placebo
NCT02174627
Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease (CKD), Not on Dialysis
Anemia
P3
Completed2,781RCT, Double-blindRoxadustat, Placebo
NCT00257205
CP-675,206 Versus Either Dacarbazine Or Temozolomide In Patients Without Prior Therapy
Melanoma
P3
Completed655RCT, Open-labeldacarbazine, CP-675,206, temozolomide
NCT00646529
Long-Term Safety of Symbicort in Asthmatic Children - SAPLING
Asthma
P3
Completed175RCT, Open-labelbudesonide/formoterol (Symbicort), budesonide (Pulmicort)
NCT02808819
A Safety Extension Study With Benralizumab for Asthmatic Adults on Inhaled Corticosteroid Plus Long-acting β2 Agonist
Asthma
P3
Completed447Open-labelBenralizumab, Benralizumab
NCT03473977
Benralizumab for Eosinophilic Gastritis (BEGS)
Eosinophilic Gastritis or Gastroenteritis
P2P3
Completed26RCT, Double-blindBenralizumab, Placebo
NCT00107107
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
Diabetes Mellitus, Type 1
P3
Completed190Open-labelpramlintide acetate
NCT02104817
Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia
Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD)
P3
Completed13,078RCT, Double-blindEpanova® (omega-3 carboxylic acids), corn oil control
NCT02110303
DIAMOND - Dual Antiplatelet Therapy to Reduce Myocardial Injury
Coronary Artery Disease
P2P3
Completed220RCT, Double-blindTicagrelor, Placebo
NCT00359879
Comparison of Exenatide Taken Before Lunch and Dinner With Before Breakfast and Dinner in Patients With Type 2 Diabetes
Type 2 Diabetes
P3
Completed377RCT, Open-labelexenatide, exenatide
NCT00114686
Efficacy and Safety of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Alcohol Dependency in Patients With Bipolar Disorder
Bipolar I Disorder, Alcohol Dependence
P3
Completed350RCT, Double-blindQuetiapine fumarate, lithium, divalproex
NCT01994720
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
Acute Ischaemic Stroke, Transient Ischaemic Attack
P3
Completed13,307RCT, Double-blindticagrelor, Acetylsalicylic acid (ASA)
NCT00888082
Protection of Ovarian Function With Goserelin Acetate in Premenopausal Early Breast Cancer Patients With Chemotherapy
Breast Cancer, Ovarian Function
P3
Withdrawn102RCT, Open-labelGoserelin acetate
NCT00683657
Safety and Efficacy Study of Subjects That Are Taking Saxagliptin Added Onto Metformin XR Compared to Subjects Taking Metformin XR Alone
Type 2 Diabetes
P3
Completed93RCT, Double-blindSaxagliptin, Placebo
NCT02322775
Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma
Asthma
P3
Completed211RCT, Double-blindBenralizumab, Placebo
NCT00654602
48-wk Open Label Phase IIIb to Evaluate Efficacy and Safety
Dyslipidaemia
P3
Completed1,500Open-labelRosuvastatin
NCT00241501
Safety of Daily Dose Esomeprazole for GERD for Pediatric and Adolescent Patients
Gastroesophageal Reflux Disease (GERD)
P3
Completed140RCT, Double-blindEsomeprazole (Nexium)
NCT00163527
Efficacy and Safety of Oral Roflumilast Taken With Low Dose Inhaled Corticosteroids in Patients With Asthma (12 to 70 y) (BY217/M2-013)
Asthma
P3
Completed2,054RCT, Double-blindRoflumilast
NCT00206310
Crestor Versus Placebo in Subjects With Heart Failure
Heart Failure
P3
Completed5,013RCT, Double-blindCRESTOR
NCT03534453
Olaparib Tablets Maintenance Monotherapy Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy
Relapsed Ovarian Cancer, Following Complete or Partial Response to Platinum Based Chemotherapy
P3
Completed229Open-labelOlaparib 300mg tablets
NCT00884663
Candesartan Versus Propranolol for Migraine Prevention
Migraine Without Aura, Migraine With Aura
P2P3
Completed72RCT, Double-blindCandesartan, propranolol, placebo
NCT02701140
Ticagrelor And PrEconditioning in Patients With coronaRy Artery diSease
Myocardial Ischemia
P2P3
Completed58RCT, Double-blind—
NCT00784680
ATAC - Quality of Life Sub-Protocol
Quality of Life
P3
Completed308RCT, Double-blindAnastrozole, Tamoxifen
NCT00423475
Radiation Therapy With or Without Goserelin in Treating Patients Who Have Undergone Surgery for Recurrent or Refractory Prostate Cancer
Prostate Cancer
P3
Completed743RCT, Open-labelgoserelin acetate
NCT00660595
Study in Schizophrenic In-patients Treated With Quetiapine Prolong or Oral Risperidone at Flexible Dose
Schizophrenic Disorders
P3
Terminated29RCT, Open-labelQuetiapine, Risperidone
NCT01256177
Evaluate the Efficacy and Safety of Quetiapine Fumarate (SEROQUEL) Extended Release as Monotherapy in the Treatment of Patients With Bipolar Depression
Bipolar Depression
P3
Completed361RCT, Double-blindQuetiapine Fumarate (SEROQUEL) Extended Release, Placebo
NCT02918071
Study to Assess Functionality, Reliability, and Performance of a Single-Use Auto-Injector With Benralizumab Administered at Home
Asthma
P3
Completed121Open-labelBenralizumab
NCT00306540
Use of Quetiapine as an Add on Therapy in the Treatment of Post Traumatic Stress Disorder
Post-Traumatic Stress Disorder
P3
Completed90RCT, Double-blindQuetiapine Fumarate, quetiapine fumarate placebo
NCT00313313
A Study of Saxagliptin in Subjects With Type 2 Diabetes Who Have Inadequate Blood Sugar Control With Sulfonylureas
Diabetes
P3
Completed768RCT, Double-blindSaxagliptin, Saxagliptin, Glyburide, Placebo, Glyburide, Metformin
NCT02875834
A Study to Investigate the Safety and Efficacy of ZS in Patients With Hyperkalemia
Hyperkalemia
P3
Completed267RCT, Double-blindSodium Zirconium Cyclosilicate (ZS) 10g, Sodium Zirconium Cyclosilicate (ZS) 5g, Sodium Zirconium Cyclosilicate (ZS) 10g, Placebo
NCT00660907
Efficacy and Safety of Dapagliflozin in Combination With Metformin in Type 2 Diabetes Patients
Type 2 Diabetes
P3
Completed1,217RCT, Double-blinddapagliflozin, glipizide, metformin hydrochloride
NCT01370538
Efficacy of Esomeprazole in Patients With Frequent Heartburn
Heartburn
P3
Completed341RCT, Double-blindEsomeprazole
NCT02446899
Efficacy and Safety of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus
Active Systemic Lupus Erythematosus
P3
Completed373RCT, Double-blindAnifrolumab, Placebo
NCT03470311
Benralizumab in Patients With Inadequate Response to Anti-IL5 Monoclonal Antibody Therapies
Severe Prednisone Dependent Eosinophilic Asthma
P3
Completed20Single-blindBenralizumab, Placebo
NCT00034892
CAFE Comparison of Atypicals in First Episode of Psychosis
Schizophrenia, Psychotic Disorders
P3
Completed—RCT, Double-blindOlanzapine, risperidone
NCT03734029
Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04]
Breast Cancer
P3
Completed557RCT, Open-labelTrastuzumab deruxtecan (DS-8201a), Capecitabine, Eribulin, Gemcitabine, Paclitaxel, Nab-paclitaxel
NCT02268214
Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes
Type 1 Diabetes Mellitus
P3
Completed833RCT, Double-blindDapagliflozin, Placebo for dapagliflozin
NCT00163358
Efficacy of Ciclesonide vs Fixed Combination of Fluticasone Propionate/Salmeterol vs Placebo in Patients With Mild Persistent Asthma (12 to 75 y) (BY9010/M1-132)
Asthma
P3
Completed630RCT, Double-blindCiclesonide
NCT00163371
Effects of Inhaled Ciclesonide Versus Fluticasone Propionate Versus Placebo on Lower Leg Growth in Prepubertal Children With Mild Persistent Asthma (6 to 12 y) (BY9010/M1-208)
Asthma
P3
Completed28RCT, Double-blindCiclesonide
NCT04053634
Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With a History of Frequent Exacerbations
Chronic Obstructive Pulmonary Disease
P3
Completed689RCT, Double-blindBenralizumab, Placebo
NCT00885378
Efficacy and Safety Study of Saxagliptin + Metformin Immediate Release (IR) Versus Metformin IR Alone in Type 2 Diabetes Mellitus
Type 2 Diabetes Mellitus
P3
Completed166RCT, Double-blindSaxagliptin plus metformin IR, Placebo plus metformin IR
NCT00254813
Fast Titration Of Quetiapine Versus Currently Approved Titration
Psychotic Disorders
P3
Completed150RCT, Open-labelQuetiapine
NCT05437510
Study of a Single Intramuscular Dose of Nirsevimab in the Prevention of Hospitalizations Due to Respiratory Syncytial Virus (RSV) Infection in Healthy Term and Preterm Infants During the First Year of Life
RSV Immunization, Healthy Volunteer
P3
Completed8,057RCT, Open-labelNirsevimab
NCT04465968
Efficacy and Safety of CRT, Durvalumab and Surgery for SST
Superior Sulcus Tumor, Non-small Cell Lung Cancer Stage IIB
P3
Not Yet Recruiting84Open-labelCisplatin, S1, Durvalumab, Durvalumab
NCT01164540
Study on the Effect of Rosuvastatin Treatment on the Prevention of Thrombosis in Patients With Previous Thrombosis
Venous Thrombosis, Pulmonary Embolism
P3
Withdrawn3,000RCT, Double-blindRosuvastatin (AZD4522), Placebo
NCT00399035
Cediranib (AZD2171, RECENTIN™) in Addition to Chemotherapy in Patients With Untreated Metastatic Colorectal Cancer
Metastatic Colorectal Cancer
P3
Completed1,254RCT, Double-blindCediranib, FOLFOX (5-fluorouracil, Leucovorin, Oxaliplatin), XELOX (Capecitabine and Oxaliplatin), Cediranib Placebo
NCT00676338
Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)
Type 2 Diabetes Mellitus
P3
Completed820RCT, Double-blindexenatide once weekly, metformin, sitagliptin, pioglitazone
NCT00666458
18-week add-on to Metformin Comparison of Saxagliptin and Sitagliptin in Adult Patients With Type 2 Diabetes (T2D)
Type 2 Diabetes
P3
Completed822RCT, Double-blindsaxagliptin, sitagliptin
NCT04625725
Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult.
COVID-19
P3
Completed5,197RCT, Double-blindAZD7442, Placebo
NCT00242294
Efficacy and Safety of Roflumilast in Japanese Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (APTA-2217-06)
Chronic Obstructive Pulmonary Disease (COPD)
P2P3
Completed570RCT, Double-blindRoflumilast
NCT00241449
A Trial Comparing the Efficacy and Tolerability of Faslodex With Nolvadex in Postmenopausal Women With Advanced Breast Cancer
Breast Cancer, Metastasis
P3
Completed51RCT, Double-blindFulvestrant, Tamoxifen
NCT02009865
Epanova® for Lowering Very High Triglycerides II (EVOLVE II)
Hypertriglyceridemia
P3
Completed379RCT, Double-blindEpanova, Olive Oil
NCT00667992
Study Comparing Budesonide Hydrofluoroalkane (HFA) vs Chlorofluorocarbon (CFC) Pressurized Metered Dose Inhalers (pMDI) in Patients With Mild to Moderate Asthma
Asthma
P3
Completed99RCT, Open-labelBudesonide HFA, Budesonide CFC
NCT00651547
Symbicort in Asthmatic Children - SEEDLING
Asthma
P3
Completed405RCT, Double-blindbudesonide/formoterol, budesonide, formoterol
NCT01942135
Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3)
Metastatic Breast Cancer
P3
Completed521RCT, Double-blindPalbociclib, Fulvestrant, Placebo, Fulvestrant
NCT00595517
Long Term Study to Investigate the Efficacy & Safety of D961H (Esomeprazole) for the Prevention of NSAIDs-induced Ulcer
Gastric Ulcer, Duodenal Ulcer
P3
Completed395Open-labelEsomeprazole 20 mg
NCT00463606
A Multicenter Study Comparing the Safety and Efficacy of ABT-335 and Rosuvastatin Calcium Combination Therapy to Monotherapy in Subjects With Dyslipidemia
Hypercholesterolemia, Dyslipidemia
P3
Completed760RCT, Double-blindABT-335 and rosuvastatin calcium, ABT-335, rosuvastatin calcium
NCT00163449
Efficacy and Safety of Ciclesonide in Preschool Children With Asthma (2 to 6 Years) (BY9010/M1-207)
Asthma
P3
Completed1,000RCT, Double-blindCiclesonide, Placebo
NCT01096017
To Investigate the Relative Efficacy of Terbutaline Turbuhaler® and Salbutamol Pressurized Metered Dose Inhaler (pMDI) a Single Blind Study
Asthma
P3
Completed24RCT, Single-blindTerbutaline Turbuhaler®, Salbutamol pMDI
NCT04385368
Phase III Study to Determine the Efficacy of Durvalumab in Combination With Chemotherapy in Completely Resected Stage II-III Non-small Cell Lung Cancer (NSCLC)
Carcinoma, Non-Small-Cell Lung
P3
Completed89RCT, Double-blindDurvalumab + SoC chemotherapy
NCT03706079
Extension Study to Evaluate the Safety and Tolerability of Tezepelumab in Adults and Adolescents With Severe, Uncontrolled Asthma
Asthma
P3
Completed951RCT, Double-blindTezepelumab
NCT00575588
52-week add-on to Metformin Comparison of Saxagliptin and Sulphonylurea, With a 52-week Extension Period
Type 2 Diabetes
P3
Completed891RCT, Double-blindMetformin, Sulphonylurea, Saxagliptin
NCT02229396
Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo
Diabetes Mellitus
P3
Completed695RCT, Double-blindExantide with Dapagliflozin, Exentide, Dapagliflozin
NCT00291759
ABCSG 8 - Adjuvant Treatment in Patients With Hormone Receptor-positive Breast Cancer With Good to Moderate Differentiation.
Breast Cancer
P3
Completed3,858RCT, Open-labelTamoxifen, Anastrozole
NCT02282020
Olaparib Treatment in Relapsed Germline Breast Cancer Susceptibility Gene (BRCA) Mutated Ovarian Cancer Patients Who Have Progressed at Least 6 Months After Last Platinum Treatment and Have Received at Least 2 Prior Platinum Treatments
Relapsed Ovarian Cancer, BRCA Mutation, Platinum Sensitivity
P3
Completed266RCT, Open-labelOLAPARIB, Single agent chemotherapy
NCT00663260
Glycemic Efficacy and Renal Safety Study of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal Impairment
Diabetes Mellitus, Type 2
P2P3
Completed631RCT, Double-blindDapagliflozin, Dapagliflozin, Placebo
NCT01395524
A 12-week Extension of the Phase III Study (D3820C00004) to Assess the Effect and Safety of NKTR-118 in Patients With Non-cancer-related Pain and Opioid-induced Constipation
Opioid-Induced Constipation (OIC)
P3
Completed302RCT, Double-blindNKTR-118, NKTR-118, Placebo
NCT03619213
Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
Heart Failure With Preserved Ejection Fraction
P3
Completed6,263RCT, Double-blindDapagliflozin, Placebo
NCT01646320
Safety and Efficacy of Dapagliflozin in Triple Therapy to Treat Subjects With Type 2 Diabetes
Type 2 Diabetes
P3
Completed320RCT, Double-blindDapagliflozin, Placebo matching with Dapagliflozin, Saxagliptin, Metformin immediate release (IR)
NCT00525824
12-week Open-label, Phase IIIb Comparing Efficacy and Safety of Rosuvastatin (CRESTOR™) in Combination With Ezetimibe
Hypercholesterolemia, Coronary Heart Disease
P3
Completed1,743RCT, Open-labelRosuvastatin (Crestor), Ezetimibe, Simvastatin
NCT00163488
Safety of Ciclesonide Nasal Spray Administered With Inhaled Fluticasone Dipropionate/Salmeterol in Adults With Perennial Allergic Rhinitis (BY9010/M1-409)
Perennial Allergic Rhinitis, Allergic Rhinitis
P3
Completed106RCT, Double-blindCiclesonide
NCT00577824
Efficacy and Safety of Exenatide in Japanese Patients With Type 2 Diabetes Who Are Treated With Oral Antidiabetic(s)
Type 2 Diabetes
P3
Completed181RCT, Double-blindexenatide, exenatide, placebo
NCT03263091
Efficacy and Safety of Roxadustat for Treatment of Anemia in Participants With Lower Risk Myelodysplastic Syndrome With Low Red Blood Cell Transfusion Burden
Primary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts), Anemia
P3
Terminated184RCT, Double-blindRoxadustat, Placebo
NCT00659841
To Assess the Safety and Efficacy of Ciclesonide, Applied as a Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (BY9010/M1-401)
Rhinitis, Allergic, Seasonal, Hay Fever
P3
Completed302RCT, Double-blindCiclesonide, Placebo
NCT00290264
SALTO - Symbicort Single Inhaler Therapy Use in Adolescent Adults and Adults With Persistent Asthma
Asthma
P3
Completed1,000RCT, Open-labelBudesonide/formoterol
NCT02794285
Long Term Safety of Anifrolumab in Adult Subjects With Active Systemic Lupus Erythematosus
Active Systemic Lupus Erythematosus
P3
Completed559RCT, Double-blindAnifrolumab, Placebo
NCT01003184
Efficacy of Once-Weekly Exenatide Versus Once or Twice Daily Insulin Detemir in Patients With Type 2 Diabetes
Type 2 Diabetes Mellitus
P3
Completed222RCT, Open-labelexenatide once weekly, insulin detemir
NCT03608358
Safety and Efficacy of Dapagliflozin in Asian T2DM Subjects With Inadequate Glycemic Control on Metformin/Saxagliptin
Type 2 Diabetes Mellitus
P3
Terminated41RCT, Double-blindDapagliflozin 10 mg, Dapagliflozin 5 mg, Dapagliflozin 10 mg placebo to match, Dapagliflozin 5 mg placebo to match, Saxagliptin 5 mg, Metformin
NCT01757275
High Dose Esomeprazole Na for Prevention of Rebleeding After Successful Endoscopic Therapy of a Bleeding Peptic Ulcer
Bleeding Peptic Ulcer
P3
Completed239RCT, Double-blindEsomeprazole Na, Cimetidine, Esomeprazole Mg
NCT02670642
Open, Randomised, Multi-center Study of on Demand Versus Continuous Esomeprazole Treatment in Patient With GERD
Gastroesophageal Reflux
P3
Completed877RCT, Open-labelEsomeprazole
NCT00543127
Fulvestrant (Faslodex) + Anastrozole (Arimidex) vs Anastrozole
Breast Cancer
P3
Terminated870RCT, Open-labelFulvestrant, Anastrozole
NCT01838499
Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
Hidradenitis Suppurativa
P2
Terminated224RCT, Double-blindMEDI8968, Saline
NCT00402896
Malignant Pleural Effusion With ZD6474
Lung Cancer, Pleural Effusion
P2
Terminated28Open-labelZD6474
NCT00672646
Study to Investigate the Analgesic Efficacy of a Single Dose of AZD1386
Pain
P2
Completed103RCT, Double-blindAZD1386, Naproxen, Placebo
NCT05459688
Open-Label Extension Study of Patients Previously Enrolled in Study CIN-107-124
Hypertension
P2
Completed175Open-labelCIN-107
NCT00103935
Study Examining Exenatide Long-Acting Release in Subjects With Type 2 Diabetes
Type 2 Diabetes Mellitus
P2
Completed45RCT, Double-blindplacebo, placebo, Exenatide LAR, Exenatide LAR
NCT06419179
Maintenance Durvalumab (MEDI4736) and Olaparib (AZD2281) After Standard 1st Line Treatment (Carboplatin/Cisplatin, Etoposide, Durvalumab) in HRD Positive Extensive Disease (ED) Small-cell Lung Cancer (SCLC)
Small Cell Lung Carcinoma
P2
By Invite29Open-labelDurvalumab, Olaparib
NCT02735239
Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal Cancer
Esophageal Cancer
P1P2
Completed73Open-labelDurvalumab, Tremelimumab, Oxaliplatin, Capecitabine, Paclitaxel, Carboplatin, 5-fluorouracil (5-FU), Leucovorin, Docetaxel
NCT03205761
Analysis of Olaparib Response in Patients With BRCA1 and/or 2 Promoter Methylation Diagnosed of Advanced Breast Cancer
Advanced Breast Cancer
P2
Completed11Open-labelOlaparib
NCT00872716
Quetiapine in Specific Phobia
Specific Phobia
P2
Completed60RCT, Double-blindQuetiapine XR
NCT03563066
Effect of Benralizumab in Atopic Dermatitis
Dermatitis, Atopic, Dermatitis
P2
Completed20RCT, Double-blindBenralizumab, Placebo Control
NCT00338130
Randomised Study to Compare the Efficacy of AZD6244 vs TMZ
Melanoma
P2
Completed239RCT, Open-labelAZD6244, Temozolomide
NCT00684307
Prevention of Stroke and Systemic Embolic Events in Patients With Atrial Fibrillation
Nonvalvular Atrial Fibrillation
P2
Completed1,084RCT, Double-blindAZD0837, Vitamin-K antagonist at INR 2-3, AZD0837
NCT02822157
Circulating Tumor DNA Guiding (Olaparib) Lynparza® Treatment in Ovarian Cancer
Ovarian Epithelial Cancer
P2
Unknown160RCT, Open-labelOlaparib, carboplatin + gemcitabine or carboplatin + paclitaxel or carboplatin + liposomal doxorubicin or liposomal doxorubicin 4-weekly or topotecan or paclitaxel weekly
NCT00238628
A Phase I/II Study of Bexarotene in Combination With ZD1839 (IRESSA®) in the Treatment of Non-Small Cell Lung Cancer
Lung Cancer
P1P2
Completed6Open-labelBexarotene, Iressa
NCT02597101
Anti-Inflammatory Small Drug Adjunctive Therapy for Type 2 Diabetes
Type 2 Diabetes Mellitus, Insulin Resistance
P2
Completed14RCT, Double-blindMetformin, saxagliptin, AZD9668, placebo
NCT03394118
TAGRISSO (Osimertinib) in NSCLC Patients in Whom T790 Mutations Are Detected by Liquid Biopsy
NSCLC
P2
Completed63Open-labelOsimertinib
NCT00986479
This is a Study to Determine the Antidepressant Effects of AZD6765
Treatment Resistant Major Depressive Disorder
P2
Completed22RCT, Double-blindAZD6765, Placebo to AZD6765
NCT00514761
Phase II Efficacy Study of AZD6244 in Colorectal Cancer
Metastatic Colorectal Cancer
P2
Completed64RCT, Open-labelAZD6244, Capecitabine
NCT00635856
Open Label Trial to Assess Iressa in Prostate Cancer Patients
Prostate Cancer
P2
Completed100Open-labelGefitinib
NCT00099580
PROCLAIM: Effect of AC2592 Administered by Continuous Subcutaneous Infusion in Subjects With Advanced Chronic Congestive Heart Failure
Congestive Heart Failure
P2
Completed61RCT, Double-blindAC2592, placebo
NCT02684318
Study to Evaluate PM01183 in Combination With Olaparib in Advanced Solid Tumors
Advanced Cancer, Ovarian Cancer
P1P2
Unknown100Open-labelPM01183 + olaparib
NCT01847092
A Study in CKD Patients With Type 2 Diabetes Mellitus and Albuminuria
Chronic Kidney Disease, Type 2 Diabetes Mellitus
P2
Completed154RCT, Double-blindAZD1722, Placebo
NCT00254579
Study of CP-675,206 in Refractory Melanoma
Refractory Melanoma
P2
Completed251Open-labelCP-675,206
NCT03871153
Chemoradiation Plus Durvalumab Followed by Surgery Followed by Adjuvant Durvalumab in Patients With Surgically Resectable Stage III (N2) Non-Small Cell Lung Cancer
Non Small Cell Lung Cancer, Stage III Non-small-cell Lung Cancer
P2
Terminated7Open-labelPaclitaxel, Carboplatin
NCT04644237
Trastuzumab Deruxtecan in Participants With HER2-mutated Metastatic Non-small Cell Lung Cancer (NSCLC)
Non-Small Cell Lung Cancer
P2
Completed152RCT, Double-blindTrastuzumab deruxtecan
NCT01201317
A Study to Investigate the Analgesic Efficacy of AZD2423 Compared With Placebo After 28 Days Treatment in Patients With Painful Diabetic Polyneuropathy
Neuropathic Pain
P2
Completed134RCT, Double-blindAZD2423, AZD2423, Placebo
NCT04230408
Intensified Chemo-immuno-radiotherapy With Durvalumab for Stage III Non-Small Cell Lung Cancers
Lung Neoplasms
P2
Completed48Open-labelDurvalumab
NCT04484935
Evaluate the Safety and Tolerability, for Nirsevimab in Immunocompromised Children
RSV Infection
P2
Completed100Open-labelNirsevimab
NCT02450656
Afatinib and Selumetinib in Advanced KRAS Mutant and PIK3CA Wildtype Non-small Cell Lung Cancer
Colorectal Neoplasms, Gastrointestinal Neoplasms
P1P2
Unknown320RCT, Open-labelAfatinib, Selumetinib, Docetaxel
NCT03235050
A Study to Evaluate the Efficacy and Safety of MEDI0382 in the Treatment of Overweight and Obese Subjects With Type 2 Diabetes
Diabetes Mellitus, Type 2
P2
Completed834RCT, Double-blindMEDI0382 low dose, MEDI0382 mid dose, MEDI0382 high dose, Placebo, Liraglutide
NCT00690482
Study to Assess the Efficacy and Safety of AZD1981 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Moderate to Severe COPD
P2
Completed118RCT, Double-blindAZD1981, Placebo
NCT00306891
Effect of Food Upon Pharmacokinetics of Single Oral Dose of Cediranib (AZD2171, Recentin™)
Cancer
P2
Completed60RCT, Open-labelCediranib, Cediranib 30 - 90 mg
NCT00303524
Comparative Study of Oestradiol Suppression: Zoladex 10.8mg/3 Month vs. 3.6mg/Month in ER +ve EBC Pre-menopausal Patients
Breast Cancer
P2
Completed170RCT, Open-labelGoserelin acetate, Goserelin acetate
NCT05383001
Randomized Phase II, Open-label Efficacy and Safety Study of Second-line Durvalumab Plus Tremelimumab Versus Platinum-based Chemotherapy Alone in Patients With NSCLC and First-line Checkpoint-inhibitor Therapy (Re-Check)
NSCLC Stage IV
P2
Withdrawn—RCT, Open-labelcombination regimen tremelimumab /durvalumab, platinum-based chemotherapy (SoC)
NCT00280865
GLAD: Dose-Finding, Efficacy, and Safety of AZ 242 (Tesaglitazar) in Subjects With Type 2 Diabetes
Type 2 Diabetes
P2
Completed500RCT, Double-blindTesaglitazar, Pioglitazone
NCT00242762
ZD1839 (IRESSA™) in Combination With Docetaxel & Cisplatin in Subjects With Metastatic Head & Neck Cancer
Head and Neck Cancer
P2
Completed36Open-labelZD1839 (IRESSA™), Docetaxel, Cisplatin
NCT00758459
Safety/Tolerability Study With AZD1236 in Chronic Obstructive Pulmonary Disease (COPD) Patients
Chronic Obstructive Pulmonary Disease
P2
Completed74RCT, Double-blindAZD1236, Placebo
NCT00298688
A Study of IRESSA in Relapsed and Refractory Small Cell Lung Cancer
Small Cell Lung Cancer
P2
Completed56Open-labelGefitinib
NCT04262388
A Multi-Cancer, Multi-State, Platform Study of Durvalumab (MEDI4736) and Oleclumab (MEDI9447) in Pancreatic Adenocarcinoma, Non-Small Cell Lung Cancer and Squamous Cell Carcinoma of the Head and Neck to Correlate Clinical, Molecular and Immunologic Parameters With DNA Methylation
Pancreatic Ductal Adenocarcinoma, Non-small Cell Lung Cancer
P2
Withdrawn—Open-labelDurvalumab, Oleclumab
NCT03782818
Olaparib for PAH: a Multicenter Clinical Trial
Pulmonary Arterial Hypertension
P1P2
Terminated17Open-labelOlaparib
NCT03705507
International Trial of Selumetinib in Combination With Dexamethasone for the Treatment of Acute Lymphoblastic Leukaemia
Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, Adult
P1P2
Terminated12Open-labelSelumetinib, Dexamethasone
NCT04675034
A Study of the Efficacy and Safety of MEDI7352 in Participants With Painful Osteoarthritis of the Knee
Painful Osteoarthritis of the Knee
P2
Completed345RCT, Double-blindMEDI7352
NCT06269484
A Phase IIb Study to Evaluate the Safety of Zibotentan/Dapagliflozin in Participants With Cirrhosis-ZEAL-UNLOCK
Liver Cirrhosis
P2
Completed73RCT, Double-blindPlacebo (placebo matching zibotentan capsule and placebo matching dapagliflozin tablet), Zibotentan + placebo (placebo matching dapagliflozin tablet), Zibotentan + dapagliflozin
NCT03809663
A Dose Ranging Placebo-Controlled Double-Blind Study to Evaluate the Safety and Efficacy of Tezepelumab in Atopic Dermatitis
Atopic Dermatitis
P2
Terminated251RCT, Double-blindTezepelumab
NCT00402077
A Study to Examine the Safety, Tolerability, and Body Weight Effect of Pramlintide Alone and in Combination With Oral Antiobesity Agents in Overweight and Obese Subjects
Overweight, Obesity
P2
Completed258RCT, Single-blindpramlintide acetate, sibutramine, phentermine, placebo
NCT00065572
Exploratory Study to Assess the Biological Activity of ZD6126 in Subjects With Newly Diagnosed Metastatic Renal Cell Carcinoma (Stage IV)
Carcinoma, Renal Cell, Kidney Neoplasms
P2
SUSPENDED—RCT, Double-blindZD6126, Placebo
NCT03829007
PD-L1 ImagiNg to prediCt Durvalumab Treatment Response in HNSCC
Head and Neck Cancer
P1P2
Completed33Open-labelDurvalumab
NCT06336356
A Study to Evaluate Cortisol Reserve in Response to Adrenocorticotropic Hormone (ACTH) Stimulation Test Following Baxdrostat Treatment Compared to Placebo in Participants With Uncontrolled Hypertension
Uncontrolled Hypertension
P2
Completed48RCT, Double-blindBaxdrostat, Placebo
NCT03337477
A Study to Evaluate a Potassium Normalization Treatment Regimen Including Sodium Zirconium Cyclosilicate (ZS) Among Patients With S-K ≥5.8
Hyperkalemia
P2
Completed70RCT, Double-blindPlacebo, Sodium Zirconium Cyclosilicate(ZS), Insulin, Glucose, Insulin, Glucose
NCT03579784
Biomarker-oriented Study of Durvalumab (MEDI4736) in Combination With Olaparib and Paclitaxel in Gastric Cancer
Advanced Gastric Cancer
P2
Unknown40Open-labelPaclitaxel, Olaparib, Durvalumab
NCT06179511
Study of AZD9829 in CD123+ Hematological Malignancies
Hematological Malignancies
P1P2
Completed56Open-labelAZD9829, AZD9829
NCT00193336
Iressa in Poor Performance Status Patients With Previously Untreated Advanced Non-Small Cell Lung Cancer
Lung Cancer
P2
Completed60Open-labelZD1839
NCT01579578
Assess the Efficacy of AZD8931 in Combination With Paclitaxel Versus Paclitaxel Alone in Patients With Gastric Cancer
Metastatic, Gastric or Gastro-oesophageal Junction, Cancer
P2
Terminated39RCT, Double-blindAZD8931, Placebo, Paclitaxel
NCT02901548
Phase 2 Durvalumab (Medi4736) for Bacillus Calmette-Guérin (BCG) Refactory Urothelial Carcinoma in Situ of the Bladder
Carcinoma in Situ of Bladder, Bladder Cancer
P2
Terminated17Open-labelDurvalumab
NCT05375760
A Randomized, Open-label, Dose-ranging Study in Adults and Pediatric Individuals ≥ 12 Years of Age to Assess the Safety, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of AZD7442, for Pre-exposure Prophylaxis of COVID-19
Coronavirus Disease 2019 (COVID-19)
P2
Terminated251RCT, Open-labelAZD7442 (tixagevimab [AZD8895] + cilgavimab [AZD1061]), AZD7442 (tixagevimab [AZD8895] + cilgavimab [AZD1061])
NCT02879617
A Clinical Trial of Durvalumab (MEDI4736) as 1st Line Therapy in Advanced Non-small Cell Lung Cancer Patients
Non-Small Cell Lung Cancer NSCLC
P2
Completed47Open-labeldurvalumab
NCT03432897
BrUOG 337: Olaparib Prior to Radical Prostatectomy For Advanced Prostate Cancer Defects in DNA Repair Genes
Prostate Cancer, Adenocarcinoma of the Prostate
P2
Terminated1Open-labelOlaparib Pill
NCT01569074
Evaluation of Safety and Effectiveness of Fostamatinib Compared to Placebo in Patients in Asia With Rheumatoid Arthritis
Rheumatoid Arthritis
P2
Terminated163RCT, Double-blindFostamatinib, Fostamatinib, Fostamatinib, Fostamatinib, Placebo
NCT00198393
Randomized Phase 2 Study of 3 Therapeutic Modalities in PS 2/3 Patients With NSCLC Stage IIIB/IV
Carcinoma, Non-Small-Cell Lung
P2
Completed126RCT, Open-labelGefitinib, gemcitabine, Docetaxel
NCT03177187
Combination Study of AZD5069 and Enzalutamide.
Metastatic Castration Resistant Prostate Cancer
P1P2
Terminated30Open-labelAZD5069, Enzalutamide 40 MG
NCT00868231
Efficacy of Aclidinium Bromide Administered in Chronic Obstructive Pulmonary Disease (COPD) Patients
Chronic Obstructive Pulmonary Disease (COPD)
P2
Completed30RCT, Double-blindAclidinium bromide 400 μg bid, Tiotropium 18 μg once-daily, Placebo
NCT00239304
Gefitinib (Iressa) in Combo With Chemoradiation in Patients With Locally Advanced Head & Neck Cancer
Head and Neck Neoplasms
P1P2
Completed40Open-labelGefitinib, Cisplatin
NCT01396226
A Multi-centre Study Comparing the Effects of AZD2927 and Placebo on the Electrical Activity in the Heart in Patients
Arrhythmia
P2
Completed20RCT, Double-blindAZD2927, Placebo
NCT03414814
Osimertinib for NSCLC With EGFR Exon 20 Insertion Mutation
Locally Advanced or Metastatic NSCLC
P2
Completed15Open-labelOsimertinib 80 MG [Tagrisso]
NCT00054691
ZD1839 (Iressa) for Recurrent or Metastatic Squamous Cell Carcinoma of the Skin
Skin Cancer
P2
Completed40Open-labelIressa
NCT00459043
Docetaxel in Combination With Zactima (ZD6474) in Patients With Locally Advanced Squamous Cell Carcinoma of the the Head and Neck
Squamous Cell Carcinoma of Head and Neck
P2
Completed30RCT, Open-labelZD6474, Docetaxel
NCT03036891
Naloxegol for Opioid-Related Gastroparesis
Gastroparesis, Opioid Use
P2
Withdrawn—RCT, Double-blindNaloxegol 25 MG Oral Tablet [Movantik], Placebo Oral Tablet
NCT00659490
Study to Investigate the Analgesic Efficacy of a Single Dose of AZD1940
Pain
P2
Completed151RCT, Double-blindAZD1940, Naproxen, Placebo
NCT01703260
Safety and Efficacy of Roflumilast and Pioglitazone in Treating Adults With Nonalcoholic SteatoHepatitis
Nonalcoholic Steatohapatitis
P2
Terminated20RCT, Double-blindRoflumilast, Pioglitazone, Placebo, Placebo
NCT00912743
Efficacy and Safety of Olaparib in Pretreated Patients With Measurable Colorectal Cancer, Stratified by Microsatellite Instability (MSI) Status
Colorectal Cancer
P2
Completed33Open-labelolaparib
NCT01136655
A Study in Asthmatic Children (6 to <12 Yrs) Comparing Single Doses of Formoterol and Foradil® Evaluating Efficacy
Asthma
P2
Completed54RCT, Double-blind80/2.25 μg Symbicort pMDI, 80/4.5 μg Symbicort pMDI, Foradil Aerolizer 12 μg, 40 μg budesonide HFA pMDI, placebo HFA pMDI
NCT00234403
A Trial to Evaluate the Combination of Iressa & Faslodex® in Patients With Advanced or Metastatic Breast Cancer
Breast Cancer
P2
Completed60Open-labelgefitinib and fulvestrant
NCT00296374
Prospective Evaluation of Proteinuria and Renal Function in Diabetic Patients With Progressive Renal Disease
Diabetes Mellitus
P2
Completed353RCT, Double-blindRosuvastatin, Rosuvastatin, Atorvastatin
NCT02311088
Trial of Caffeine to Alleviate Dyspnea Related to Ticagrelor
Dyspnea
P2
Terminated26RCT, Double-blindCaffeine, Placebo
NCT00687297
Study of Vandetanib Combined With Chemotherapy to Treat Advanced Non-small Cell Lung Cancer
Lung Cancer, Non Small Cell Lung Cancer
P2
Completed162RCT, Double-blindvandetanib induction, Docetaxel, Carboplatin, Placebo, Vandetanib maintenance
NCT02891161
Durvalumab And Radiation Therapy Followed by Adjuvant Durvalumab in Patients With Urothelial Cancer (T2-4 N0-2 M0) of the Bladder
Urothelial Cancer
P1P2
Terminated26Open-labeldurvalumab
NCT03570476
Olaparib Before Surgery in Treating Participants With Localized Prostate Cancer
Prostate Adenocarcinoma Without Neuroendocrine Differentiation, Stage I Prostate Cancer AJCC v8
P2
Terminated2Open-labelOlaparib
NCT04170543
A Phase 2b Diabetic Kidney Disease Study
Diabetic Kidney Disease
P2
Completed609RCT, Double-blindMEDI3506, Placebo, Dapagliflozin
NCT01043185
A Study to Estimate Effect of 4 Different Doses of AZD3355 on Reflux Episodes, Which Patients With Gastroesophageal Reflux Disease (GERD) May Experience
Gastroesophageal Reflux Disease
P2
Completed27RCT, Double-blindAZD3355, AZD3355, AZD3355, AZD3355, placebo
NCT00950599
Study of Multiple Doses of Saxagliptin (BMS-477118)
Type 2 Diabetes Mellitus
P2
Completed423RCT, Double-blindSaxagliptin, Saxagliptin, Saxagliptin, Saxagliptin, Saxagliptin, Saxagliptin, Placebo
NCT03522584
Durvalumab, Tremelimumab and Hypofractionated Radiation Therapy in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma
P1P2
Terminated6Open-labelDurvalumab, Tremelimumab
NCT02319044
Phase II Study of MEDI4736, Tremelimumab, and MEDI4736 in Combination w/ Tremelimumab Squamous Cell Carcinoma of the Head and Neck
Recurrent/Metastatic Squamous Cell Carcinoma of Head & Neck
P2
Completed267RCT, Open-labelMEDI4736, Tremelimumab, MEDI4736 + Tremelimumab
NCT02482298
A Study to Assess the Effect of Ticagrelor in Reducing the Number of Days With Pain in Patients With Sickle Cell Disease
Sickle Cell Disease
P2
Completed87RCT, Double-blindTicagrelor, Placebo
NCT00242749
IRESSA in Combination With Cisplatin & Radiotherapy in Patients With Advanced Head & Neck Carcinoma
Cancer of Head and Neck
P2
Completed47Open-labelGefitinib, Cisplatin and Radiotherapy
NCT00206245
A Dose-finding Phase IIb Study With AZD0865 and Esomeprazole in GERD Patients With Erosive Esophagitis.
GERD With Erosive Esophagitis
P2
Completed1,400RCT, Double-blindAZD0865
NCT03145194
TIMES: Ticagrelor vs. Placebo/ Clopidogrel With Aspirin in Anterior STEMI Patients Treated With Primary PCI
ST Elevation Myocardial Infarction
P2
Unknown140RCT, Double-blindTicagrelor
NCT04327024
Study of Verinurad in Heart Failure With Preserved Ejection Fraction
Heart Failure With Preserved Ejection Fraction (HFpEF)
P2
Completed159RCT, Double-blindVerinurad, Allopurinol, Placebo for verinurad, Placebo for allopurinol
NCT03234153
Neoadjuvant Immunotherapy With Durvalumab and Tremelimumab for Bladder Cancer Patients Ineligible for Cisplatin
Muscle-invasive Bladder Cancer
P2
Terminated6Open-labelDurvalumab (Imfinzi), Tremelimumab
NCT01904773
Safety, Tolerability, Pharmacokinetic, and Efficacy Study of AZD5213 in Adolescents With Tourette's Disorder
Tourette Syndrome
P2
Completed29RCT, Double-blindAZD5213 and placebo
NCT01065662
AZD2171 and Temsirolimus in Patients With Advanced Gynecological Malignancies
Endometrial Cancer, Ovarian Cancer
P1
Completed11Open-labeltemsirolimus, cediranib
NCT00899470
Bioequivalence Study of Saxagliptin and Glucophage Combination Formulations in Healthy Subjects (A)
Type 2 Diabetes Mellitus
P1
Completed24RCT, Open-labelCo-administration of Saxagliptin and Metformin IR, Fasted, Saxagliptin/Metformin, Fasting, Co-administration of Saxagliptin and Metformin IR, Fed, Saxagliptin/Metformin, Fed
NCT00738842
Uric Acid Study in Healthy Male Volunteers
Gout, Coronary Artery Disease
P1
Completed24RCT, Double-blindAZD6140, Placebo to match AZD6140
NCT03273127
To Assess the Pharmacokinetics, Safety and Tolerability of Abediterol Administered Once Daily for 9 Days, in Patients With Asthma on Inhaled Corticosteroids
Asthma
P1
Completed12RCT, Single-blindAbediterol, Placebo
NCT06715670
A Study to Investigate the Blood Concentrations of 4 Different Oral Doses of Zibotentan in Healthy Non-Asian and Japanese Participants
Liver Cirrhosis
P1
Completed30RCT, Open-labelZibotentan
NCT05419401
A Study to Investigate the Absolute Bioavailability, Absorption, Metabolism, Distribution and Excretion of [14C]AZD5363 (Capivasertib)
Healthy Volunteer
P1
Completed7Open-labelCapivasertib film-coated tablet, 200 mg, [14C]AZD5363 (Capivasertib)
NCT02588105
Study to Assess the Safety and Preliminary Efficacy of AZD0156 at Increasing Doses Alone or in Combination With Other Anti-cancer Treatment in Patients With Advanced Cancer
Advanced Solid Tumours
P1
Completed84Open-labelAZD0156, Olaparib, irinotecan, Fluorouracil, Folinic Acid
NCT00799331
Exploratory Study to Assess the Pharmacokinetics of AZD5985
Healthy
P1
Completed32RCT, Double-blindAZD5985, placebo
NCT06754761
Human ADME Study of [14C]-Ceralasertib (AZD6738) and Absolute Bioavailability of Ceralasertib
Neoplasm
P1
Terminated2Open-label[14C] AZD6738, AZD6738 / ceralasertib
NCT02585973
Dose-escalating AZD1775 + Concurrent Radiation + Cisplatin for Intermediate/High Risk HNSCC
Carcinoma, Squamous Cell of Head and Neck
P1
Completed12Open-labelAZD1775, Cisplatin
NCT06675175
A Phase 1b Study to Assess the Safety, Tolerability, and Pharmacodynamics of AZD4144 in Participants With Established Atherosclerotic Cardiovascular and Chronic Kidney Disease.
Chronic Kidney Disease, Atherosclerotic Cardiovascular Disease
P1
Completed29RCT, Double-blindAZD4144
NCT01146756
MEK Inhibitor and Thoracic Radiotherapy Trial
Non Small Cell Lung Cancer
P1
Completed21Open-labelAZD6244
NCT00720421
A Sedation/Cognition/Electroencephalogram (EEG) Study Using AZD7325 and Comparator.
Healthy Volunteer
P1
Completed16RCT, Double-blindAZD7325, AZD7325, AZD7325, Lorazepam, Lorazepam
NCT02317016
Study to Assess the Effect of AZD9291 on the Blood Levels of Rosuvastatin, in Patients With EGFRm+ Non-small Cell Lung Cancer
Non Small Cell Lung Cancer
P1
Completed44Open-labelAZD9291 tablet dosing, Rosuvastatin
NCT04256629
A Study to Assess the Effect of Verinurad on the Electric Activity of the Heart
Healthy Volunteers (Intended Indication: Chronic Kidney Disease)
P1
Completed24RCT, Double-blindVerinurad, Placebo, Allopurinol
NCT02308072
Phase I Study of Olaparib Combined With Cisplatin-based Chemoradiotherapy to Treat Locally Advanced Head and Neck Cancer
Head and Neck Cancer
P1
Completed16Open-labelOlaparib, Cisplatin
NCT02718911
A Study of LY3022855 in Combination With Durvalumab or Tremelimumab in Participants With Advanced Solid Tumors
Solid Tumor
P1
Completed72Open-labelLY3022855, Durvalumab, Tremelimumab
NCT01083212
To Evaluate the Effect of Gemfibrozil on the Pharmacokinetics and Pharmacodynamics of a Single Dose of AZD1656
Type 2 Diabetes Mellitus
P1
Completed19RCT, Open-labelAZD1656, Gemfibrozil, Placebo
NCT01500018
Study in Healthy Recreational Polydrug Users to Measure the Abuse Potential of TC-5214
Drug Abuse, Healthy
P1
Withdrawn—RCT, Double-blindTC-5214, TC-5214 Placebo, Ketamine, Phentermine, TC-5214, TC-5214, Phentermine
NCT05110976
A Study to Investigate the Safety, Tolerability and Effects of AZD8630 in Healthy Subjects and Subjects With Asthma on Inhaled Corticosteroids and Long-acting Beta-agonists
Asthma
P1
Completed170RCT, Double-blindAZD8630, Placebo
NCT00844324
Bioequivalence Study in Healthy Subjects
Hypertension
P1
Completed36RCT, Open-labelCandesartan cilexetil, Candesartan cilexetil
NCT00497679
AZD1152 in Patients With Advanced Solid Malignancies-Study 3
Solid Tumours
P1
Terminated45Open-labelAZD1152
NCT01664624
Roflumilast Plus Alogliptin Proof-of-Mechanism Study in Type2 Diabetes
Type 2 Diabetes
P1
Completed40RCT, Double-blindRoflumilast, Alogliptin, Exenatide, Placebo to roflumilast, Placebo to alogliptin
NCT02093351
To Assess Safety and Effect of Olaparib on the Pharmacokinetics of Anastrozole, Letrozole & Tamoxifen, and Their Effect on Olaparib, in Patients With Advanced Solid Cancer
Solid Tumours
P1
Completed79Open-labelOlaparib, Tamoxifen, Anastrozole, Letrozole
NCT03804645
A Study to Assess the Reaction of Body for Four Different Formulations of AZD9977 (Part A) and Influence of Food and Lower Dose of a Selected Formulation (Part B) in Healthy Male Subjects
Heart Failure
P1
Completed12RCT, Open-labelTreatment A, Treatment B, Treatment C, Treatment D
NCT03649165
A Study to Evaluate Bioavailability and Food Effect of Selumetinib (AZD6244) in Healthy Male Participants
Neurofibromatosis Type 1 (NF1)-Related Plexiform Neurofibromas (PNs), Healthy Participants
P1
Completed24RCT, Open-labelTreatment A, Treatment B, Treatment C, Treatment D, Acetaminophen
NCT00986531
The Effects AZD8529 on Cognition and Negative Symptoms in Schizophrenics
Schizophrenia
P1
Completed59RCT, Double-blindAZD8529, Placebo to match AZD8529
NCT01358383
Assessment of Pharmacokinetics of a Single Oral Dose of VIMOVO in Healthy Adult Volunteers
Juvenile Idiopathic Arthritis
P1
Completed28Open-labelnaproxen, esomeprazole
NCT01403922
To Determine Blood Pressure Interaction Between TC-5214 and Anti-Hypertensive Medications (Calcium Channel Blockers, Beta Blockers, and ACE Inhibitors) in Patients With Chronic Hypertension
Chronic Hypertension
P1
Terminated80RCT, Double-blindTC-5214, TC-5214
NCT02484729
A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD9977 After Single Ascending Doses to Healthy Males
Safety, Tolerability
P1
Completed196RCT, Single-blindAZD9977, oral suspension, Placebo, oral suspension, AZD9977, oral solution
NCT00901290
Determine the Effects of C-administration of AZD7325 and an Oral Contraceptive in Healthy Female Subjects
Pharmacokinetics
P1
SUSPENDED56RCT, Double-blindmonophasic oral contraceptive, AZD7325
NCT01562210
Olaparib Dose Escalating Trial + Concurrent RT With or Without Cisplatin in Locally Advanced NSCLC
NSCLC
P1
Completed28Open-labelOlaparib, Cisplatin
NCT00858325
Pharmacokinetic Study of Daptomycin in Healthy Chinese Subjects Living in China
Healthy
P1
Completed24Open-labelDaptomycin
NCT05438303
Study to Assess the Effect of Co-Administration of AZD9833 on the Pharmacokinetics of Midazolam, of Omeprazole, of Celecoxib and of Dabigatran Etexilate in Healthy Postmenopausal Female Volunteers
Healthy Volunteers
P1
Completed59RCT, Open-labelAZD9833, Midazolam, Omeprazole, Dabigatran Etexilate, Celecoxib
NCT01744288
Study to See if Platelet Transfusion Stop or Lessen the Effect of the Drug on Platelets
Inhibition on Platelet Aggregation
P1
Completed258RCT, Open-labelTicagrelor, Clopidogrel, ASA
NCT03368196
DS-8201a in Patients With Cancer That Tests Positive for Human Epidermal Growth Factor Receptor 2 (HER2) Protein
Adenocarcinoma, Gastric, Neoplasm, Breast
P1
Completed12Open-labelDS-8201a
NCT02934607
A Study to Assess How Much Drug Reaches the Blood When Given From Symbicort pMDI With Spacer Compared to That of Symbicort pMDI Without Spacer in Healthy Volunteers
Study is Being Conducted in Healthy Volunteers
P1
Completed50RCT, Open-labelSymbicort pMDI with spacer device, Symbicort pMDI without spacer device
NCT05963009
Baxdrostat Bioavailability and Bioequivalence Study
Hypertension
P1
Completed14RCT, Open-labelbaxdrostat (formerly CIN-107) oral solution
NCT00967356
AZD5985 Single Ascending Dose Study
Healthy
P1
Terminated72RCT, Double-blindAZD5985, Placebo
NCT02010970
A Phase I Study in Healthy Volunteers to Assess the Effect of Cytochrome3A4 (CYP3A4) Inhibitors (Diltiazem and Itraconazole) on the Pharmacokinetics (PK) of AZD3293 and the Effects of AZD3293 on the Pharmacokinetics of Midazolam, a Cytochrome 3A4 and Cytochrome 3A5 (CYP3A4/CYP3A5) Substrate
Healthy Volunteers, Pharmacologic Action
P1
Completed56Open-labelGroup 1 AZD3293, Group 2 AZD3293, Group 3 AZD3293, Group 1 Itraconazole, Group 2 Diltiazem, Group 3 Midazolam
NCT01034982
AZD9668 Relative Bioavailability
Chronic Obstructive Pulmonary Disease
P1
Completed28RCT, Open-labelAZD9668, AZD9668
NCT01469923
To Assess the Safety, Tolerability, Pharmacokinetics and Pharmakodynamics of AZD2820 After Multiple Ascending Doses
Obesity
P1
Terminated18RCT, Single-blindAZD2820, Placebo
NCT01355354
Effects of Administration of Fostamatinib on Blood Concentrations of Digoxin in Healthy Subjects
Healthy Volunteers, Rheumatoid Arthritis
P1
Completed21Open-labelDigoxin, Fostamatinib
NCT00904176
Study of the Effect of Dapagliflozin on the Pharmacokinetics of Warfarin or Digoxin in Healthy Subjects
Type 2 Diabetes Mellitus
P1
Completed30RCT, Open-labelDapagliflozin, Warfarin, Digoxin
NCT01392807
Open-label Study to Assess the Pharmacokinetics of NKTR-118 in Patients With Impaired Hepatic Function
Hepatic; Functional Disturbance
P1
Completed24Open-labelNKTR-118
NCT00687232
Safety, Tolerability and Pharmacokinetics of Inhaled Doses of AZD4818 in Healthy Japanese Male Volunteers
Healthy
P1
Completed30RCT, Single-blindAZD4818, Placebo
NCT00667147
Phase I Abraxane Weekly and Three Weekly Schedule With Vandetanib
Solid Tumors
P1
Completed65RCT, Open-labelWeekly Abraxane and Daily Vandetanib, Abraxane every three weeks and daily vandetanib
NCT01739647
A Single Dose Study to Assess the Safety, Effects, and Blood and Urine Drug Levels of AZD3293 in Healthy Subjects
Healthy Young Volunteers, Healthy Elderly Volunteers
P1
Completed72RCT, Double-blindAZD3293, Placebo
NCT07500987
Phase I Study of [111In]-FPI-2107 in EGFR Mutation-positive NSCLC
EGFR Mutation-positive NSCLC
P1
Terminated6Open-label[111In]-FPI-2107, FPI-2053
NCT00689039
Study of an Extended Release (ER) Tablet, Single and Repeated Dosing
Healthy
P1
Completed94RCT, Single-blindAZD1305, Placebo
NCT00770302
Assess Pharmacokinetics, Safety and Tolerability in Healthy Chinese Volunteers After Oral Doses of Saxagliptin
Type 2 Diabetes
P1
Completed34Open-labelSaxagliptin
NCT02400333
Study to Assess the Bioavailability of Ticagrelor OD Tablet vs. IR Tablet
Bioavailability, Healthy Subjects
P1
Completed100RCT, Open-labelTicagrelor OD tablet (90 mg single dose) administered with 200 ml of water, Ticagrelor OD tablet (90 mg single dose) administered without water, Ticagrelor OD tablet (90 mg single dose) suspended in water administered via nasogastric tube, Brilique®, Ticagrelor IR tablet (90 mg) administered with 200mL of water
NCT02063204
To Assess the Pharmacokinetics, Safety and Tolerability of Selumetinib in Renal Impaired Subjects and Healthy Subjects
Solid Tumours
P1
Completed24Open-labelselumetinib
NCT03545087
A Study of Lanabecestat in Participants With Severe Kidney Impairment Compared to Healthy Participants
Renal Insufficiency
P1
Withdrawn—Open-labelLanabecestat, Iohexol
NCT05587998
A Study to Assess the Effect of AZD4041 on Respiratory Drive in Recreational Opioid Users.
Opioid Use Disorder
P1
Completed45RCT, Double-blindMorphine, AZD4041
NCT04449484
Multiple Ascending Dose Study of MEDI1341 in Patients With Parkinson's Disease
Parkinson's Disease
P1
Completed25RCT, Double-blindMEDI1341
NCT05166421
Study to Evaluate Pharmacokinetic Comparability Between AZD7442 Co-formulation (AZD8895 + AZD1061) vs AZD8895 and AZD1061 Individually in Adult Healthy Participants
Corona Virus Disease
P1
Completed224RCT, Open-labelAZD7442, AZD8895 (clonal cell line material), AZD1061 (clonal cell line material), AZD8895 (cell pool material), AZD1061 (cell pool material)
NCT00920608
A Study to Assess the Pharmacokinetics of Methotrexate Given With and Without AZD9056 in Rheumatoid Arthritis Patients
Rheumatoid Arthritis
P1
Withdrawn12Open-labelAZD9056, Methotrexate
NCT02508155
A Study of MEDI7352 in Painful Osteoarthritis of the Knee
Chronic Pain
P1
Completed132RCT, Double-blindMEDI7352 for IV infusion, Placebo for IV infusion, MEDI7352 for Subcutaneous Injection, Placebo for Subcutaneous Injection
NCT01525225
Study of Saxagliptin, 5-Hydroxy Saxagliptin, and Metformin Concentrations/Levels in Pediatric Subjects With T2DM
Type 2 Diabetes Mellitus
P1
Terminated4Open-labelMetformin immediate release (IR), Saxagliptin, Metformin IR, Saxagliptin/Metformin XR FDC, Metformin XR
NCT04073160
TRIO Bladder: A Study of Durvalumab Plus Tremelimumab Followed by Concurrent Durvalumab Plus Bladder Radiation in Muscle-Invasive Bladder Cancer
Bladder Cancer
P1
Withdrawn—Open-labelTremelimumab, Durvalumab, Intravesicular Therapy
NCT05236543
A Study to Assess the Pharmacokinetics of AZD4831 When Administered Alone and in Combination With Itraconazole
Healthy Volunteers
P1
Completed21Open-labelAZD4831, Itraconazole
NCT00785915
AZD6765 Single and Multiple Ascending Dose Study in Healthy Male and Female Japanese and Caucasian Subjects
Healthy
P1
Completed40RCT, Double-blindAZD6765, Placebo
NCT07069725
The Phase 1, Open-label, PET Trial Designed to Investigate the Effect of AZD2389 on FAP Occupancy in the Liver in Participants With Advanced Liver Fibrosis.
Liver Fibrosis, Hepatic Cirrhosis
P1
Completed8Open-labelAZD2389
NCT01226602
Study to Assess the Effect of Ticagrelor on Coronary Blood Flow in Healthy Male Subjects.
Blood Flow Speed, Coronary Flow Velocity
P1
Completed39RCT, Double-blindAZD6140, Placebo
NCT00712465
An Interaction Study With Digoxin and AZD1305
Atrial Fibrillation
P1
Completed18RCT, Open-labelAZD1305, Digoxin
NCT01839604
A Phase I/Ib Study of AZD9150 (ISIS-STAT3Rx) in Patients With Advanced/Metastatic Hepatocellular Carcinoma
Advanced Adult Hepatocellular Carcinoma, Hepatocellular Carcinoma Metastatic
P1
Completed58Open-labelAZD9150
NCT00866385
AZD8566 Food Effect/Microtracer Study
Healthy Volunteer Study
P1
Completed21RCT, Open-labelAZD8566, AZD8566 IV carbon labelled
NCT00973076
Study to Assess the Safety and Tolerability of the Tor Kinase Inhibitor AZD8055
Cancer, Solid Tumors
P1
Completed19Open-labelAZD8055
NCT03635164
Radiotherapy With Durvalumab Prior to Surgical Resection for HPV Negative Squamous Cell Carcinoma
Squamous Cell Carcinoma of the Head and Neck
P1
Completed21Open-labelDurvalumab
NCT05848843
A Phase I Study of Adagrasib and Durvalumab for Treatment of Advanced Non-small Cell Lung Cancers and Gastro-intestinal Cancers Harboring KRAS G12C Mutations
Lung Cancer, Gastro-intestinal Cancer
P1
Withdrawn—RCT, Open-labelDurvalumab, Adagrasib
NCT01783197
Study of Selumetinib in Patients With Previously Treated or Untreated Advanced/Metastatic NSCLC
Non Small Cell Lung Cancer
P1
Completed39Open-labelPaclitaxel, Carboplatin, Selumetinib, Pemetrexed, Cisplatin
NCT00600496
A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886)
Breast Cancer, Breast Neoplasms
P1
Completed140Open-labelAZD6244, Dacarbazine, Erlotinib, Docetaxel, Temsirolimus
NCT05457270
A Study to Assess the Relative Bioavailability and Safety of Different Formulations of AZD4831 in Fasted State in Healthy Volunteers.
Healthy Volunteers
P1
Completed30RCT, Open-labelAZD4831
NCT01030224
This is a Study to Evaluate the Safety, Tolerability and Pharmacokinetics (PK) of AZD9742 After Single IV Doses in Healthy Subjects
Healthy
P1
Completed48RCT, Double-blindAZD9742, Placebo to match AZD9742
NCT00681720
Positron Emission Tomography (PET) Study With (11C)Flumazenil to Determine Central GABAA Receptor Occupancy of AZD7325
Anxiety
P1
Completed4Open-labelAZD7325, Radioligand (11C) flumazenil
NCT02039180
Relative Bioavailability Study to Assess Two Solid Formulations Compared to an Oral Solution of AZD3293 in Healthy Male and Non-Fertile Female Subjects
Healthy Volunteers, Pharmacologic Action
P1
Completed1RCT, Open-labelAZD3293 oral solution, AZD3293 tablet formulation A, AZD3293 tablet formulation B
NCT00930215
Study Comparing Gelatine Capsule 40 mg D961H and HPMC Capsule in Japanese Healthy Males
Healthy
P1
Completed48RCT, Open-labelD961H, D961H
NCT05848440
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of AZD9550 Following Single Ascending Dose Administration to Healthy Participants
Non-alcoholic Steatohepatitis
P1
Completed48RCT, Double-blindAZD9550, AZD9550, Placebo
NCT01264250
A Study to Assess the Safety, Tolerability and Pharmacokinetics After Single Ascending Intravenous Doses of AZD2927 in Healthy Male Volunteers
Healthy
P1
Completed48RCT, Double-blindAZD2927, Placebo
NCT00497991
Safety, Tolerability, PK and Efficacy of AZD1152 in Patients With Relapsed Acute Myeloid Leukemia
Myeloid Leukemia
P1
Completed65Open-labelAZD1152
NCT02346890
A Phase 1 Study to Examine the Effect of Renvela on the Pharmacodynamics of AZD1722
Healthy
P1
Completed16RCT, Open-labelAZD1722, Renvela
NCT01809210
Assess Safety & Efficacy of Selumetinib When Given in Combination With Standard First Line Treatment for Advanced Non-small Cell Lung Cancer
Locally Advanced or Metastatic NSCL Cancer Stage IIIB IV
P1
Completed55Open-labelselumetinib, gemcitabine, cisplatin, carboplatin, pemetrexed
NCT04994106
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of AZD5462 Following Single and Multiple Ascending Dose Administration to Healthy Volunteers
Healthy Participants
P1
Completed98RCT, Double-blindAZD5462, Placebo
NCT06795906
A Safety, Pharmacokinetic, and Pharmacodynamic Study of Once Daily Inhaled AZD8630 in Adults With Asthma
Asthma
P1
Completed24Double-blindAZD8630
NCT02968914
Pharmacokinetic Comparability of Benralizumab Using Accessorized Pre-Filled Syringe or Autoinjector in Healthy Volunteers
Asthma, Chronic Obstructive Pulmonary Disease
P1
Completed180RCT, Open-labelBenralizumab, Benralizumab
NCT06651021
A Phase I PK Study of Balcinrenone/Dapagliflozin in Healthy Chinese Participants
Healthy Volunteer
P1
Completed10Open-labelbalcinrenone/dapagliflozin
NCT01160926
Dual REctcal Angiogenesis or MEK Inhibition radioTHERAPY Trial
Rectal Cancer
P1
Terminated31Open-labelAZD6244, Cediranib (AZD2171)
NCT07423598
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics With AZD0780 Following Repeated Dose Administration in Healthy Adults With Elevated LDL-C Levels
Healthy Participants
P1
Completed40RCT, Double-blindAZD0780, Placebo
NCT00790114
Determine the Effect of Multiple Doses of AZD7325, CYP Study
Healthy Volunteer
P1
Completed24RCT, Double-blindAZD7325, Midazolam, Caffeine
NCT05662033
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics (PK) of Oral AZD6793 in Healthy and Chronic Obstructive Pulmonary Disease Participants, to Assess the Relative Oral Bioavailability Between Two Formulations, and the Food Effect on the PK of AZD6793 Compared to Fasting State.
Inflammatory Diseases
P1
Completed93RCT, Single-blindAZD6793, Placebo
NCT00389389
Phase I, Open-Label, Dose-Escalation Study of AZD4877 in Solid Tumors
Neoplasms
P1
Completed75Open-labelAZD4877
NCT03588546
FASENRA SCEI for Long-term Use
Asthma
Completed653——
NCT00770250
National Survey on Asthma
Asthma
Completed1,704——
NCT03131362
Realize the Current Situation of COPD Patients in China
Chronic Obstructive Pulmonary Disease COPD
Completed5,020——
NCT02316990
China Survey of Stress Ulcer Bleeding in Critically Ill Neurosurgical Patients
Stress Ulcers, Stress-related Mucosal Disease (SRMD)
Completed1,416——
NCT01160679
Effectiveness of Atypical Antipsychotics on Anhedonic Features in Patients With Schizophrenia
Schizophrenia
Completed231——
NCT01208779
Epidemiology Study in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer
Hormon Receptor Positive Breast Cancer
Completed90——
NCT05020717
Retrospective Survey of Hyperkalemia in Hemodialysis
Hemodialysis Complication
Unknown300——
NCT06455462
Patient Characteristics, Treatment Patterns and Outcomes of Patients With Severe Asthma Treated With Tezepelumab in the Real World; a Retrospective, Observational Medical Chart Review Conducted in UK Severe Asthma Centres
Severe Asthma
Completed352—Tezepelumab
NCT01130961
Management of Advanced Non-Small Cell Lung Cancer (NSCLC) and Clinical Outcomes in Patients Who Received Gefitinib in Thailand
Lung Cancer
Completed104——
NCT01275794
Screening Epidemiological Program on Compensation Evaluation of Diabetes Mellitus Type 2 (DMT2) Patients on Oral Anti-diabetic (OAD) Monotherapy and Physicians Satisfaction of Their Usage
Type 2 Diabetes
Completed1,849——
NCT02226822
DISCOVERing Treatment Reality of Type 2 Diabetes in Real World Setting in Japan
Type 2 Diabetes Mellitus
Completed1,869——
NCT06321731
Real-World Outcomes in COPD Patients Starting Trixeo (Budesonide/Glycopyrronium/Formoterol) in Spain.
Chronic Obstructive Pulmonary Disease (COPD)
Completed718——
NCT00928629
Audit and Screening Study to Determine the Prevalence of Peripheral Arterial Disease
Peripheral Arterial Disease
N/A
Completed1,000Open-label—
NCT05548777
Andexanet Alfa and 4F-PCC Use in Patients Hospitalised With an Anticoagulant-related Major Bleed
Anticoagulant-related Major Bleed
Completed5,480—Andexanet alfa, 4F-PCC
NCT00681837
Prevalence of Gastroesophageal Reflux During Childhood and Teenage Years in France
Gastroesophageal Reflux
Completed2,500——
NCT00785057
Retrospective Treatment Pattern Survey for the Patient With and Without History of Stroke
Hypertension
Completed1,000——
NCT00233584
Pulmicort Asthma Prevention (Post-PAC)
Asthma
N/A
Completed400Open-label—
NCT02695121
Cancer in Patients on Dapagliflozin and Other Antidiabetic Treatment
Breast Cancer, Bladder Cancer
Completed2,133,575——
NCT07103629
Bringing Knowledge About Chronic Kidney Disease in Brazil: Filling the Gap
Renal Insufficiency, Chronic
Completed8,428——
NCT06614712
OPTIMISE-CKD Study_current Clinical Landscape in Spain
Renal Disease
Completed91,628——
NCT05932901
OPTIMISE-CKD Drug Utilization
Chronic Kidney Disease
Completed2,682,052——
NCT00699959
National Survey on Coronary Patients and Heart Failure Performed in 2 Patient Groups
Coronary Patients, Heart Failure
Completed1,650——
NCT05180396
A Study on Disease Awareness and Treatment Compliance of Heart Failure Patients
Heart Failure
Completed200——
NCT01164397
Efficiency of Rosuvastatin Versus the Fixed Combination of Ezetimibe/Simvastatin in Outpatients
Dyslipidemia
Completed268——
NCT01944618
forREAL: FORXIGA PRESCRIPTION EVENT MONITORING PROGRAM (PEMP)
Type 2 Diabetes
Terminated5,000—Forxiga
NCT06131424
NIS Study Determining Prevalence of HER2-low in Metastatic Breast Cancer Patients
HER2-negative
Completed1,151——
NCT00680082
Observational Usage Study of Statins in Primary Care in France
Healthy
Completed2,100——
NCT04901260
AMAZE™ Asthma Implementation QI Study
Asthma
Completed117——
NCT04391283
First Line Osimertinib for EGFR Mutation-positive Non-Small Cell Lung Cancer in Real World Chinese Setting
Carcinoma, Non-Small-Cell Lung
Unknown500—Osimertinib
NCT03258788
A Translational Study Investigating PD-L1 Expression After Radiotherapy for Non-small Cell Lung Cancer
Non-Small Cell Lung Cancer
Completed15——
NCT04696692
Single-Cell Map of Immune and Lymphoma Cells in B-cell Non-Hodgkin's Lymphoma
Diffuse Large B-cell Lymphoma
N/A
Completed60Open-label—
NCT00882336
European Study of Cardiovascular Risk
Cardiovascular Risk Factors, Hyperlipidemia
Completed7,200——
NCT00692874
Quality of Life Analysis of Treatment in Patients With Prostate Cancer on Adjuvant Zoladex Therapy
Prostate Cancer
Completed1,646——
NCT01292018
Management of Dyslipidemia in Adult Type 2 Diabetes Patients in India
Dyslipidemia, Type 2 Diabetes Mellitus
Completed5,400——
NCT01199536
Helicobacter Pylori Eradication Treatment in Patients With Duodenal Ulcers
Duodenal Ulcer
Completed59——
NCT02733601
Epidemiology of Breast Cancer in Women Based on Diagnosis Data From Oncologists and Breast Surgeons in Algeria
Oncology, Epidemiology
Completed1,500——
NCT04878237
Kinetics of Nasal Cytokine Responses to Mechanical Stimulation
Allergic Rhinitis Due to Grass Pollen, Allergic Asthma
N/A
Completed30Open-label—
NCT05663957
eVusheld Assessment reaL wORld Effectiveness in the VA Health System
SARS-CoV-2, COVID-19
Completed5,814—Evusheld
NCT00913731
Quality Project to Evaluate and Validate the FAST-O Rating Scale
Acute Psychotic Symptoms
Completed111——
NCT04884269
A Non Interventional Pilot Study on Machine Learning for ILD Detection Based on the Patient Data From Digital Devices in Unresectable Stage III Non-Small Cell Lung Cancer Patients Receiving Durvalumab
Carcinoma, Non-Small-Cell Lung
Completed144——
NCT03721289
Evaluation in Real World of Molecular Testing and Treatment Patterns for EGFR Mutation in Lung Cancer Patients
Carcinoma, Non-Small-Cell Lung
Completed463——
NCT00434460
Study of Knowledge Translation of Clinical Practice Guidelines for Ventilator Associated Pneumonia
Ventilator Associated Pneumonia
Completed1,320——
NCT00533260
A Non-interventional Naturalistic Project to Investigate the Effect of the Use of SMS Text Service on Treatment Adherence in Patients Treated With Seroquel® (Quetiapine)
Bipolar Disorder, Schizophrenia
Completed128——
NCT03798535
First Real-world Data on Unresectable Stage III NSCLC Patients Treated With Durvalumab After Chemoradiotherapy
NSCLC
Completed1,156——
NCT03038789
XIGDUO Extended Release (XR) Post Marketing Surveillance
Adult Patients With Type 2 Diabetes Mellitus
Completed623——
NCT01202617
Seroquel XR in the Long Term Treatment of Schizophrenia
Relapse in Schizophrenia
Completed1,606——
NCT07764835
Prospective Evaluation of Hepatocellular Carcinoma Surveillance in At-Risk Patients (Screening HCC)
Hepatocellular Carcinoma, Liver Cirrhosis
Not Yet Recruiting300——
NCT02695095
Acute Liver Injury in Patients on Dapagliflozin
Acute Liver Injury
Completed424,091——
NCT01106781
A Non-interventional Survey on the EGFR (Epidermal Growth Factor Receptor) Mutation Status in Completely Resected Chinese Non-Small Cell Lung Cancer (NSCLC) Patients With Adenocarcinoma Histology
Non-Small Cell Lung Cancer
Completed591——
NCT05826366
Imfinzi/Imjudo NSCLC Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - CEI/SCEI
Carcinoma, Non-Small-Cell Lung
Completed296——
NCT02962492
An Investigation Into the Effect of Dapagliflozin on Ketogenesis in Type 1 Diabetes
Evaluate Ketogenic Stress
N/A
Completed70RCT, Double-blindExenatide/Exenatide extended release, Dapagliflozin, Placebo
NCT03137264
Resistance & Activating Mutations Diagnosed Among NSCLC Community Dwelling EGFR Mutation Positive Patients
Non-small Cell Lung Cancer
Completed44—Other
NCT01110564
Study to Investigate Daily Symptom Variability, Symptom Effects on Morning Activities of Chronic Obstructive Disease
Chronic Obstructive Pulmonary Disease
Completed515——
NCT01298739
Asthma Control Study 2011
Asthma Control Level
Completed1,524——
NCT06676436
Observational Study on the Treatment of Patients With Metastatic Breast Cancer
Cancer
Completed204——
NCT00880711
Faslodex International Observational Non-Interventional Study in Advanced Breast Cancer (BC)
Breast Cancer
Completed57——
NCT01921127
Comparative Effectiveness of Symbicort vs. Advair Among COPD Patients
COPD
Completed3,000——
NCT07392710
Clinical Evaluation of the Nova Max Pro StatSensor Device
Kidney Transplant, Kidney Disease, Chronic
N/A
Completed100Open-label—
NCT02305680
Long-term Follow-up of antithrombotIc Management Patterns in Acute Coronary Syndrome Patients in Asia-China Extension
Acute Coronary Syndromes
Completed2,334——
NCT07103642
EXACERBATIONS AND REAL-WORLD OUTOMES AMONG PATIENTS WITH COPD INITIATING BREZTRI (EROS+CP Japan Study)
Pulmonary Disease, Chronic Obstructive
Completed3,402—BGF
NCT00696527
National Survey on Infiltrative Breast Cancer
Infiltrative Breast Cancer
Completed1,500——
NCT03642613
The Study for Evaluating Factors Relating to Daily Step Counts and Physical Activity in Japanese Patients With COPD.
Pulmonary Disease, Chronic Obstructive
Completed505——
NCT06514144
Exacerbations Among Patients Receiving Breztri (EROS Study)
Pulmonary Disease, Chronic Obstructive
Completed2,409—BGF
NCT02506816
Preoperative Olaparib Endometrial Carcinoma Study (POLEN)
Endometrial Carcinoma
Completed36—Olaparib
NCT02955316
Irritable Bowel Syndrome Survey in Gastroenterological Adult Outpatients in China
Irritable Bowel Syndrome (IBS)
Completed3,000——
NCT01776684
Evaluation of EGFR TKI Resistance Mechanism Using Plasma DNA Analysis
EGFR Mutation Positive Non-small Cell Lung Cancer
N/A
Unknown200Open-labelEGFR TKIs (gefitinib, erlotinib, afatinib, et al)
NCT00879736
A Study of the Effect of Patient Education (Talking Health Together) in Improving Doctor-patient Communication
Doctor-patient Communication Improvement
N/A
Completed322RCT, Single-blind—
NCT06998095
Tezepelumab (Tezspire) Regulatory Postmarketing Surveillance in Korea
Severe Asthma, Chronic Rhinosinusitis With Nasal Polyps(CRSwNP)
Not Yet Recruiting210——
NCT01678339
Sicilian Administrative Data Base Study in Acute Coronary Syndrome Patients
Acute Coronary Syndrome, Acute Myocardial Infarction
Withdrawn———
NCT04149067
Study of Real-world Evidence With SGLT2i (Dapagliflozin) and DPP4i (Sitagliptin) in Type 2 Diabetes Patients in Spain
Diabetes Mellitus, Type 2
Completed1,080—Dapagliflozin, Sitagliptin
NCT00946452
Symbicort SMART Satisfaction From Patient Perspective 2009
Asthma
Completed205——
NCT00683306
Open Label Extension Study With Gefitinib (IRESSA™) for Completing Trial Patients Who May Benefit From Further Treatment
Non Small Cell Lung Cancer (NSCLC)
APPROVED_FOR_MARKETING——ZD1839 (Iressa)
NCT00689455
Regional Observatory on Metabolic Syndrome- LAZIO
Metabolic Syndrome
Completed1,574——
NCT01194843
Placebo-controlled Evaluation of Ropivacaine Efficacy by Local Infiltrations
Hepatectomy, Pain
N/A
Completed85RCT, Double-blindRopivacaine, Physiological serum
NCT04928417
Exacerbations and Their Outcomes International (EXACOS International)
Chronic Obstructive Pulmonary Disease
Completed1,762——
NCT00638391
Ax-003/Arimidex (Anastrozole) in the Adjuvant Therapy of Early Breast Cancer
Breast Cancer
Completed1,600—Anastrozole
NCT03375450
Treatment and Exacerbation in COPD Subjects
Comparative Effectiveness Study
Completed60,243——
NCT02459990
Congenital Malformations and Maternal Use of Anti-hypertensive Medication in the United Kingdom
Hypertension
Completed22,000——
NCT05950997
A Single Arm Study of Acalabrutinib Conbimed With Obinutuzumab in Chinese Patients With Previously Untreated CLL
Chronic Lymphocytic Leukemia
N/A
Unknown89Open-labelAcalabrutinib, Obinutuzumab
NCT00944489
To Assess Adherence to the Treatment and Quality of Life in Patients With Hypertension
Hypertension
Completed1,150——
NCT06056778
The Prevalence Evaluation of Systemic Lupus Erythematosus in Russian Patients With Reproductive Issues (PRISMA)
Systemic Lupus Erythematosus
Completed628——
NCT00738725
BioImage Study: A Clinical Study of Burden of Atherosclerotic Disease in an At-Risk Population
Plaque, Atherosclerotic Disease
Completed7,687——
NCT01767974
Comparison of Sequencing and PNA Clamping of EGFR Gene in Patients With Non-Small Cell Type Lung Cancer
Non-Small Cell Lung Cancer
Unknown140——
NCT07674121
PROLONG (PRostateOLaparibONcombinationGcc) Study
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Not Yet Recruiting75—Olaparib and Abiraterone Combination
NCT01185314
To Study the Changes in Protein in Lung Cells of Asian Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
Non Small Cell Lung Cancer
N/A
Completed1,270Open-label—
NCT02234973
Transformation of Indigenous Primary Healthcare Delivery
Type 2 Diabetes Mellitus
Completed500——
NCT02990117
ICS Treatment Compliance of Asthma Patients
Asthma, Allergic
Completed350——
NCT05461378
PREP (Pre-Exposure Prophylaxis) of COVID-19
Immuno-Deficiency, COVID-19
Completed138—Evusheld
NCT00681707
Retrospective Treatment Pattern Survey for the Patients With Hypertension and Stroke
Hypertension
Completed1,000——
NCT01694758
OPtimal Type 2 dIabetes Management Including Benchmarking and Standard Treatment in CEEMEA
Diabetes Mellitus, Non-Insulin-Dependent
Completed733——
NCT01814943
The Risk of Uncomplicated Peptic Ulcer in a Cohort of Secondary Prevention Aspirin Users
Uncomplicated Peptic Ulcer
Completed39,000——
NCT03212287
Brilinta Clinical Experience Investigation
Acute Coronary Syndrome, Old Myocardial Infarction
Completed663——
NCT00970918
Study of Artery Conditions of 'At-risk' Asian People Not on Lipid-lowering Drugs
Cardiovascular Disease
N/A
Completed2,609—Blood sample testing for hs-CRP
NCT00842387
Evaluation Study of a Management Strategy for Gastroesophageal Reflux Disease (GERD)
Reflux, Heartburn
Completed2,370——
NCT03517917
Prospective Tissue Collection Research Protocol
Solid Tumor
Completed221——
NCT07800858
Baxdrostat and Molecular Imaging of Adrenal Cytoreduction in Primary Aldosteronism
Primary Aldosteronism
N/A
Not Yet Recruiting30Open-labelbaxdrostat
NCT06073574
CARDIO-TTRansform Magnetic Resonance Imaging (MRI) Sub-study
Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)
Completed160——
NCT00523679
Symbicort SMART (Symbicort Maintenance And Reliever Therapy)
Asthma
Completed2,000——
NCT04125290
US Post-Marketing Safety Study of Moxetumomab Pasudotox-tdfk (LUMOXITI)
Hairy Cell Leukemia
Terminated2——
NCT00320970
Angiotensin II Antagonism of TGF-Beta 1
Diabetic Nephropathy, Hypertension
N/A
Completed36Open-labelCandesartan
NCT04207203
Healthy Diet Rich in Potassium to Chronic Kidney Disease With Sodium Zirconium Cyclosilicate: A Feasibility Study
Chronic Kidney Disease stage4, Chronic Kidney Disease Stage 5
N/A
Completed26Open-label—
NCT00916513
Quality of Life and Treatment Satisfaction of People With Type 2 Diabetes: A European Survey
Diabetes
Completed5,926——
NCT05712096
eVusheld Assessment reaL wORld Effectiveness in Israel Clalit Health Services
SARS-CoV-2, COVID-19
Completed4,000—EVUSHELD
NCT01874262
A Study to Evaluate the Use of Mobile-phone Based Patient Support in Patients Diagnosed With Myocardial Infarction
Myocardial Infarction
N/A
Completed174RCT, Open-label—
NCT02805361
Real World Assessment of Clinical Outcome Changes -Including Month of Ramadan-for Dapagliflozin in Management of Type II Diabetes Mellitus
Type II Diabetes Mellitus
Completed511——
NCT02695082
Acute Kidney Injury in Patients on Dapagliflozin and Other Antidiabetic Medications
Acute Kidney Injury
Completed539,310——
NCT01395550
Secondary Prevention Treatment in Patients Who Have Suffered a Cardiovascular Event
Cardiovascular Events
Completed88——
NCT06039683
A Multicountry, Multicentre, Non-interventional, Retrospective Study to Determine Real-world Treatment Patterns and Associated Outcomes After First Line Osimertinib in Patients With Advanced and Metastatic NSCLC EGFRm in the GCC Region
Carcinoma, Non-Small-Cell Lung
Completed54——
NCT01917643
Comparative Effectiveness of Symbicort vs. Spiriva Among COPD Patients
COPD Exacerbation
Completed2,396——
NCT06365593
hATTR Polyneuropathy in Russia
Hereditary Transthyretin Amyloidosis
Completed100——
NCT01338363
Drug Utilization and Safety Events Among Children Using Esomeprazole, Other Proton Pump Inhibitors or H2-receptor Antagonists
Hospitalized Cases of Angioneurotic Oedema, Pneumonia
Completed23,470——
NCT01781416
Level of Concordance Between Patients Perception and Physicians Evaluation of Cardiovascular Risk
Cardiovascular Risk
Completed799——
NCT01426893
Observational Study to Evaluate the Correctness of the Use of Inhaler Device in Patients With Asthma or Chronic Obstruct
Asthma,, Chronic Obstructive Pulmonary Disease
Completed310——
NCT05532995
Responses to CPET in Subjects With Persistent Exercise Intolerance After COVID-19: an Open-Source Exercise Network
COVID-19
Completed1,200——
NCT00597168
Quality of Life in Schizophrenic Patients
Schizophrenia
Completed124——
NCT00900861
Asthma Control and Clinical Practice in Hungary 2009
Asthma Control Level
Completed3,000——
NCT05774431
Disparities in the Proportion of Ticagrelor and Prasugrel-eligible Patients with Acute Coronary Syndrome in a Real-world Registry
Acute Myocardial Infarction
Completed6,789——
NCT04105153
Real-world Analysis of Workup at Disease Progression and Implementation of Osimertinib for EGFR+ NSCLC
EGFR Positive Non-small Cell Lung Cancer
Completed400——
NCT00984373
Epidemiology of Schizophrenia in Bulgaria
Schizophrenia
Completed440——